Key Takeaways Werner trades at a discount forward P/S ratio compared to its industry average, signaling a cheap valuation.Werner has a consistent track record of paying out dividends since 1987. WERN stock has gained in the past three months, and outperforms its industry and peers like ODFL and KNX. Werner Enterprises, Inc. (WERN - Free Report) looks cheap from a valuation standpoint. Considering the forward 12-month price-to-sales ratio (P/S-F12M), Werner is trading at a discount compared to the industry.
The stock has a forward 12-month P/S-F12M of 0.70X compared with 2.66X for the industry over the past five years. The company’s forward 12-month P/S-F12M ratio is also below the median level of 0.74X over the past five years. These factors indicate that the stock’s valuation is attractive. WERN has a Value Score of A.
Werner P/S Ratio (Forward 12 Months) Vs. Industry Image Source: Zacks Investment Research
Now, the question is whether it is worth buying, holding, or selling the Werner stock at current prices. Let us delve deeper to find out.
Tailwinds Working in Favor of Werner StockWerner's top line continues to benefit from strength across both its Truckload Transportation Services segment and Logistics segment. The company stands strong on the back of its dedicated revenue and fleet size growth, FirstFleet acquisition, improving rates and a robust 95% customer retention rate. Restructuring in its One-Way Truckload business has also helped WERN witness a rise in revenue per truck. Growth in Intermodal and Final Mile is aiding Logistics revenues. With constant cost reduction efforts and focus on safety, service and innovation, Werner is hopeful of delivering improved financial results as market conditions tighten throughout the year.
WERN’s solid balance sheet increases financial flexibility. The company ended first-quarter 2026 with cash and cash equivalents of $61.54 million, higher than the current debt level of $8.60 million. This implies that the company has sufficient cash to meet its current debt obligations.
Further, Werner’s current ratio (a measure of liquidity) at the end of first-quarter 2026 stood at 1.44, which is higher than the industry's reading of 1.10. The favorable comparison with respect to the current ratio looks encouraging. This may imply that the risk of default is less. Also, a current ratio greater than 1.0 is usually considered good for a company.
A strong balance sheet enables the company to reward shareholders with dividends and share repurchases. WERN has a consistent track record of paying out dividends since 1987. Dividend-paying stocks like WERN are generally safe bets for creating wealth, as these payouts act as a hedge against economic uncertainty. As a reflection of its shareholder-friendly stance, in 2022, WERN paid dividends of $32.1 million and repurchased shares worth $110.4 million. In 2023, WERN paid dividends of $34.20 million (did not repurchase any shares). In 2024, WERN paid dividends of $35.1 million and repurchased shares worth $67.1 million.
During 2025, WERN paid dividends of $34.1 million and repurchased shares worth $55.5 million. As of March 31, 2026, WERN had 5.0 million shares remaining under its share repurchase authorization. Such shareholder-friendly initiatives should boost investor confidence and positively impact the bottom line.
WERN Stock’s Price PerformanceShares of WERN stock have gained 35.3% over the past three months, outperforming the transportation-truck industry’s 9.8% surge, as well as that of other industry players, Old Dominion Freight Line, Inc. (ODFL - Free Report) and Knight-Swift Transportation Holdings Inc. (KNX - Free Report) within the same time frame.
WERN Stock’s Three-Month Price Comparison Image Source: Zacks Investment Research
What Do Earnings Estimates Say for WERN?The positive sentiment surrounding WERN stock is evident from the fact that the Zacks Consensus Estimate for the third quarter of 2026 and the fourth quarter of 2026 earnings has been revised upward in the past 90 days. The consensus mark for 2026 and 2027 earnings has also been projected northward in the past 90 days.
The favorable estimate revisions indicate brokers’ confidence in the stock.
Image Source: Zacks Investment Research
Time to Buy WERN StockIt is understood that WERN stock is currently attractively valued. Consistent shareholder-friendly initiatives boost investor confidence and positively impact the bottom line. WERN has a consistent track record of paying out dividends since 1987. A solid balance sheet allows the company to continue paying dividends and buying back shares, reflecting its pro-shareholder stance. Apart from being shareholder-friendly, Werner's top line continues to benefit from strength across both its Truckload Transportation Services segment and Logistics segment.
We believe that the positives surrounding the stock (as highlighted throughout the write-up) outweigh the concerns regarding rising expenses related to salaries, wages, and benefits, equipment, maintenance, fuel, and other expenses and driver shortage issues. We, therefore, suggest investors add Werner stock to their portfolios for healthy returns. The company’s Zacks Rank #1 (Strong Buy) further supports our thesis. You can see the complete list of today’s Zacks #1 Rank stocks here.
Host Hotels zvýšil výhled růstu srovnatelného hotelového RevPAR na 3–4,5 % a celkového RevPAR na 3,5–5 % po silném 1. čtvrtletí 2026. Akcie HST za tři měsíce vzrostly o 18,8 %.
Key Takeaways HST shares gained 18.8% in three months, supported by demand in key U.S. and Sunbelt markets.HST raised 2026 comparable hotel RevPAR and total RevPAR growth guidance after a strong first quarter.Host Hotels backs growth with capital recycling, strong liquidity and ongoing dividends and share repurchases. Shares of Host Hotels & Resorts Inc. (HST - Free Report) have gained 18.8% in the past three months compared with the industry’s growth of 2.3%.
Host Hotels, which has a portfolio of luxury and upper-upscale hotels in top U.S. markets and the Sunbelt region, is poised to benefit from the strong demand drivers in these markets.
Strong leisure demand and improving group business are expected to support the RevPAR growth through healthy occupancy trends. Also, a strategic capital-recycling program and a healthy balance sheet augur well.
Analysts seem positive on this lodging REIT, which currently carries a Zacks Rank #3 (Hold). The Zacks Consensus Estimate for its 2026 FFO per share has been revised 2 cents northward to $2.13 over the past month.
Image Source: Zacks Investment Research
Factors Behind HST’s Share Price RiseHost Hotels has a strong Sunbelt exposure and a presence in the top 21 U.S. markets. Its properties are strategically located in central business districts, near major airports and resort and conference destinations, which support both leisure and business travel demand.
In the first quarter of 2026, comparable hotel RevPAR rose 4.4% year over year, while comparable hotel total RevPAR increased 4.6%. Reflecting solid demand trends, management raised full-year 2026 comparable hotel RevPAR growth guidance to 3-4.5% and total RevPAR growth guidance to 3.5-5%. The outlook is supported by continued leisure and group travel demand, as well as incremental demand expected from major events, including the 2026 FIFA World Cup. With supply growth in its markets and chain scales remaining low, this backdrop should support continued RevPAR growth.
Host Hotels continues to sell non-strategic assets and redeploy the proceeds into higher-quality hotels and portfolio reinvestment. Per the company’s May 2026 Investor Presentation, from 2021 to 2026, it completed $2.9 billion of dispositions at a 16.2x EBITDA multiple. Its acquisitions during this period totaled $3.3 billion at a 13.3x EBITDA multiple. With the hotel transaction activity remaining relatively muted, the company’s scale and investment-grade balance sheet provide the flexibility to pursue acquisitions and continue capital recycling when valuations are favorable.
Host Hotels maintains a strong balance sheet that provides flexibility to reinvest in its portfolio. As of March 31, 2026, the company had approximately $3.4 billion of total available liquidity. Total debt was approximately $5.1 billion, with a weighted average maturity of 4.9 years and a weighted average interest rate of 4.8%. The company had no significant debt maturities in 2026. Net leverage was 2.5x on a credit facility basis, while 99% of the consolidated portfolio was unencumbered, underscoring its financial flexibility. This strong liquidity position should help Host Hotels fund its 2026 capital program while preserving financial flexibility for acquisitions and shareholder returns, including dividends and share repurchases.
Host Hotels continues to emphasize shareholder returns through dividends and repurchases. The board authorized a regular quarterly dividend of 20 cents per share and a special dividend of 72-cent per share, payable in mid-July to stockholders of record at the end of June. During the first quarter, the company repurchased 4.0 million shares for $75 million at an average price of $18.97, and it had $405 million of remaining authorization at quarter end. This supports continued capital returns to shareholders.
With the factors mentioned above, the positive trend in the stock is expected to continue in the near term.
Risks Likely to Affect HST’s Positive TrendMacroeconomic uncertainty and a cautious approach by many businesses are likely to hurt demand for its properties in the near term. The competitive landscape and elevated interest expenses are other concerns.
Stocks to ConsiderSome better-ranked stocks from the broader REIT sector are Cousins Properties (CUZ - Free Report) and Welltower (WELL - Free Report) , each carrying a Zacks Rank of #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for CUZ’s 2026 FFO per share is pegged at $2.95, which indicates year-over-year growth of 3.87%.
The Zacks Consensus Estimate for WELL’s full-year FFO per share is pinned at $6.32, which calls for an increase of 19.47% from the year-ago period’s level.
Note: Anything related to earnings presented in this write-up represents FFO, a widely used metric to gauge the performance of REITs.
Bank of America zvýšila cílovou cenu SharkNinja na 165 USD z 145 USD a potvrdila doporučení Buy po silnějších domácích tržbách. Prodeje v USA podle Nielsen vzrostly o 17 % a 86,2 % pro týdny končící 20. a 27. června; na souhrnné bázi pak meziročně o 51,5 %.
SharkNinja Inc (NYSE:SN.) received a higher price target from Bank of America, which raised its price objective to $165 from $145 and reiterated its 'Buy' rating after stronger domestic sales trends lifted its second quarter sell-through estimates.
Shares of SharkNinja currently trade at about $150, up almost 35% so far this year.
The firm wrote that Nielsen point-of-sale data showed domestic SharkNinja product sell-through increased 17% and 86.2% for the weeks ending June 20 and June 27, respectively. On a combined basis, sell-through rose 51.5% year over year, supported by the timing of Amazon's Prime Day and upward revisions to prior weeks.
Bank of America wrote that SharkNinja's second quarter 2026 domestic sell-through is now tracking at 25.7%, up from 18.4% two weeks earlier and well ahead of estimated industry growth of 2.6%.
Based on the stronger sales performance, the firm’s improved price target was reached by applying an approximately 23x price-to-earnings multiple to the its 2027 earnings estimate, compared with 20x previously.
The analysts also highlighted SharkNinja's direct-to-consumer business, with the firm estimating those channels contribute 200 to 300 basis points to overall sales growth.
Bank of America wrote that several SharkNinja products have recently gained traction on TikTok, aided by summer demand and influencer engagement. The analysts pointed to strong online interest in products including the Ninja SLUSHi, ChillPill, and Ninja Frost Vault Cooler, with multiple videos generating millions of views in recent weeks.
The firm also highlighted top-selling products on SharkNinja's TikTok Shop, including the Ninja Single-Serve Specialty Coffee Maker, Ninja Belgian Waffle Maker Pro, Ninja SLUSHi Professional Frozen Drink Maker, and Shark HydroDuo and Shark StainStriker cleaning products.
PacBio těží z vývoje produktů a zisku nad odhady v 1. čtvrtletí, ale slabší výzkumné financování dál brzdí poptávku po systémech Revio a Vega. Firma nečeká výrazné zlepšení výzkumného financování do roku 2026.
Key Takeaways PacBio gains from product development and a Q1 earnings beat despite funding challenges.PACB's SPRQ-Nx chemistry boosts yields and targets sub-$300 genome sequencing at scale.PacBio sees research funding uncertainty weighing on Revio and Vega demand through 2026. Pacific Biosciences of California, Inc. (PACB - Free Report) , popularly known as PacBio, has been gaining from its continued product development. The optimism, led by strong first-quarter results, is expected to contribute further. However, concerns about funding headwinds persist.
In the year-to-date period, this Zacks Rank #2 (Buy) company’s shares have lost 11.2% compared with the 12.4% decline of the industry. The S&P 500 Composite has improved 9.4% in the said time frame.
The renowned global provider of sequencing systems has a market capitalization of $521.8 million. The company projects 22.6% growth for 2026 and expects to maintain its strong performance in the future. PacBio’s earnings surpassed the Zacks Consensus Estimate in all the trailing four quarters, delivering an average surprise of 29.8%.
Image Source: Zacks Investment Research
Factors Favoring PACB’s GrowthSequencing Technologies Strengthen Market Leadership: PacBio differentiates itself in the genomics industry through its proprietary HiFi long-read sequencing, based on Single-Molecule Real-Time (SMRT) technology. This technology enables the high-accuracy, real-time detection of complex genomic structures, such as structural variations, haplotypes and epigenetic modifications.
Per a report by Data Bridge Market Research, the global SMRT market size was valued at $2.88 billion in 2024 and is projected to reach $4.36 billion by 2032, at a CAGR of 5.3%. Additionally, PacBio has expanded its offerings by integrating Sequencing by Binding chemistry with the launch of its Onso system in 2022, a short-read platform delivering ≥90% of bases at Q40+ accuracy, 15 times more precise than traditional sequencing methods. By providing both long-read and short-read technologies, PacBio uniquely serves diverse research and clinical applications while driving down costs and enhancing variant detection.
Robust Product Portfolio Driving Growth: PacBio continues to strengthen its competitive position through innovation in its HiFi sequencing platform. The company's SPRQ-Nx chemistry is gaining traction, delivering higher sequencing yields and enabling human whole-genome sequencing costs below $300 at scale through reusable SMRT Cells. Management plans to extend the technology to the Vega platform later this year, enhancing throughput and workflow efficiency.
PacBio is also advancing its next-generation ultra-high-throughput sequencing platform to target large-scale clinical and population genomics opportunities. Additionally, its collaboration with Basecamp Research to sequence roughly 100,000 metagenomic samples highlights the expanding role of HiFi sequencing in AI-driven biological research and underscores the technology's growing adoption across emerging applications.
Strong Q1 Results: PacBio exited the first quarter of 2026 with mixed results, wherein earnings beat the Zacks Consensus Estimate while revenues missed the same. Stable top-line performance, despite softer instrument sales, reflected continued strength in consumables demand and improving utilization trends across the installed base.
Growth in consumables revenues, expansion across the EMEA region and disciplined expense management were encouraging. The company also reported a significantly narrower operating loss year over year, supported by lower operating expenses and continued restructuring benefits.
A Factor That May Offset PACB’s GainsFunding Headwinds Continue to Weigh on Instrument Demand: PacBio continues to face funding-related headwinds that are weighing on instrument demand, particularly across academic and government research markets. Uncertainty around grant funding and cautious capital spending have pressured purchases of both Revio and Vega systems, with Vega being more exposed to academic budget constraints.
While the company is seeing growing interest from clinical and commercial customers, management does not anticipate a meaningful recovery in research funding through 2026 and recently lowered the high end of its annual revenue outlook due in part to weaker instrument demand. Although the upcoming commercial launch of SPRQ-Nx chemistry could improve the attractiveness of PacBio’s sequencing platforms by lowering costs and boosting throughput, near-term instrument growth is expected to remain dependent on expanding clinical adoption rather than a broad recovery in research spending.
Estimate TrendPacBio has been witnessing a stable estimate revision trend for 2026. Over the past 30 days, the Zacks Consensus Estimate for its adjusted loss per share has remained stable at 41 cents.
The Zacks Consensus Estimate for 2026 revenues is pegged at $165.8 million, indicating a 3.6% increase from the year-ago reported numbers.
Other Key PicksSome other top-ranked stocks from the broader medical space are Globus Medical (GMED - Free Report) , West Pharmaceutical (WST - Free Report) and Intuitive Surgical (ISRG - Free Report) .
Globus Medical, currently carrying a Zacks Rank #2, reported a first-quarter 2026 adjusted earnings per share (EPS) of $1.12 per share, which surpassed the Zacks Consensus Estimate by 22.1%. Revenues of $759.9 million beat the Zacks Consensus Estimate by 4.0%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
GMED has an estimated long-term earnings growth rate of 10.2% compared with the industry’s 12.6% growth. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 26.3%.
West Pharmaceutical, currently carrying a Zacks Rank #2, reported first-quarter 2026 EPS of $2.13, which beat the Zacks Consensus Estimate by 26.8%. Revenues of $844.9 million surpassed the Zacks Consensus Estimate by 8.5%.
WST has an estimated long-term earnings growth rate of 13.9% compared with the industry’s 9.5% growth. The company’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 19.4%.
Intuitive Surgical, carrying a Zacks Rank #2 at present, reported first-quarter 2026 adjusted EPS of $2.50, which beat the Zacks Consensus Estimate by 20.2%. Revenues of $2.77 billion surpassed the Zacks Consensus Estimate by 6.2%.
ISRG has a long-term estimated growth rate of 14.6% compared with the industry’s 12.6% growth. The company’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 16.8%.
Reddit posiluje bezpečnost AI: zavádí ověřování botů, detekci spamu a soukromé ověřování lidí, aby chránil autentické diskuse. Cílí na 100 milionů denních uživatelů v USA.
Key Takeaways Reddit is expanding AI safety with bot verification, spam detection and privacy-focused human checks. RDDT aims to protect authentic conversations through stronger moderation, transparency and safety tools. Reddit targets 100 million daily U.S. users through product, onboarding and community improvements. Reddit (RDDT - Free Report) is benefiting from its accelerated focus on AI safety and user trust, which has become a cornerstone of its growth strategy in 2026. The company’s leadership recognizes that authentic human conversation is a scarce and increasingly valuable asset in the digital age.
With more than 25 billion posts and comments and nearly 500 million weekly users, Reddit’s platform is uniquely positioned to provide real human perspectives, an essential resource for both AI model training and genuine user engagement. To protect the integrity of this large collection of human-generated content, Reddit has increased its AI safety efforts by advancing bot verification, increasing transparency around automated accounts, and adopting secure authentication technologies such as Passkeys.
Further expanding its AI safety initiatives, Reddit has outlined new measures to preserve authentic human conversations as AI-generated content becomes more common online. The company is expanding AI-powered detection systems to identify spam, fake engagement, and coordinated manipulation while strengthening human oversight and moderator tools.
Reddit is also introducing privacy-focused human verification methods to distinguish real users from bots without compromising anonymity. RDDT will continue investing in safety technologies, transparency, and community-driven moderation to ensure discussions remain trustworthy. These efforts are designed to protect Reddit’s unique value as a platform built on genuine human experiences and conversations in the AI era.
Reddit’s commitment to AI safety and user trust is expected to be a key driver of both user growth and monetization. The company’s goal to reach 100 million daily U.S. users is underpinned by ongoing improvements in product quality, onboarding and community support.
RDDT Faces Stiff CompetitionRDDT is facing stiff competition from competitors like Meta Platforms (META - Free Report) and Snap (SNAP - Free Report) . Both Meta Platforms and Snap are also expanding their footprint in the AI space.
Meta Platform is benefiting from its accelerating growth into artificial intelligence (AI), which is driving significant top-line growth. Meta Platform’s release of the Muse family of models and the upgraded Meta AI assistant has positioned the company as a leader in personal superintelligence, with billions of users now accessing these AI-powered features. This surge in AI-driven engagement is translating directly into top-line growth, as evidenced by a 33% year-over-year increase in total revenues to $56.3 billion for the quarter.
Snap has introduced a suite of AI-powered advertising tools to help brands create, optimize and personalize campaigns on Snapchat. New features include AI-assisted campaign setup, image-to-video generation, creative enhancement, conversational AI Sponsored Snaps and creator marketplace automation, aimed at improving engagement, commerce and advertising performance across its platform.
RDDT’s Share Price Performance, Valuation, and EstimatesRDDT shares have plunged 12.6% year to date, underperforming the broader Zacks Computer & Technology sector’s 14.7% increase and the Internet - Software industry’s 11.2% decline.
RDDT Stock Performance
Image Source: Zacks Investment Research
RDDT shares are overvalued, with a forward 12-month Price/Sales of 10.19X compared with the Computer & Technology sector’s 6.88X. RDDT has a Value Score of F.
RDDT's Valuation
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for 2026 earnings is pegged at $4.83 per share, which has been unchanged over the past 30 days. This suggests 84.35% year-over-year growth.
Reddit currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Bank of America vidí Figma jako vítěze AI, protože generativní umělá inteligence podle ní zvyšuje poptávku po spolupráci při vývoji produktů. Akcie Figma byly v době zveřejnění o 9,49 % výše.
The brokerage said Figma’s stock has fallen about 85% from its 52-week high as investors worried that generative AI would reduce the need for design software.
However, Bank of America believes AI is expanding demand for collaborative product development and creating new monetization opportunities through Figma’s hybrid seat-based and usage-based pricing model.
The firm values Figma at 8 times estimated 2027 enterprise value-to-sales, above the peer average of about 5.9 times, citing the company’s stronger growth outlook and growing role in AI-powered software development.
AI Seen Driving AdoptionBank of America said AI is increasing the number of people creating digital products while also making workflows more complex. That, in turn, should increase demand for a centralized platform where designers, developers and product teams can collaborate.
The analysts pointed to early evidence that AI is already contributing to revenue growth. During the first quarter of 2026, 75% of enterprise customers that exceeded their AI credit limits purchased additional credits, while more than 95% remained active on the platform. Enterprise customers generating more than $100,000 in annual recurring revenue increased 48% year over year, while net dollar retention reached 139%.
Growth OutlookBank of America projects revenue growth of 35.6% in 2026 and 23% in 2027, compared with peer averages of 19.3% and 15.7%, respectively. The brokerage expects AI investments to pressure margins in the near term but forecasts operating margin expansion from 9.2% in 2026 to 13.8% by 2028, alongside improving free cash flow margins.
The analysts also highlighted continued enterprise adoption as a key growth driver. They estimate the number of customers generating more than $100,000 in annual recurring revenue will grow 26.2% in 2026 before moderating to more than 22% annually through 2028.
Risks RemainDespite its bullish stance, Bank of America said risks include slower-than-expected AI adoption, increasing competition from AI-native design tools and weaker monetization of AI features. Even so, the firm believes those concerns are already reflected in Figma’s valuation and views the company as an AI beneficiary rather than an AI casualty.
FIG Stock Price Activity: Figma shares were up 9.49% at $23.08 at the time of publication on Tuesday, according to Benzinga Pro data.
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
Image Credits:Figma Figma is trying to become more than a design platform by adding more AI and bringing the coding and prototyping layer closer to its canvas. Toward that end, it has acquired the team behind the vibe-coding and AI agent platform Bud (formerly Orchids).
“Figma is one of, if not the, defining product companies of our time to capitalize on this. It’s where ideas start, iterate, and come to life, and a natural home for this exciting new era of work,” Bud’s CEO Kevin Lu posted on X.
The Y Combinator-backed startup began as a vibe-coding platform letting users spin up apps for mobile, web, Slack, browser, and more. It later rebranded as Bud, an agent platform that can access various services, browse the web, and write code to automate tasks.
Under the deal, the startup will shut down both Bud and Orchids by July 18, requiring users to migrate their projects by then.
Earlier this year, citing a security researcher, the BBC reported that apps created on Orchids were susceptible to cyberattacks.
Figma didn’t specify how it aims to use this team, but recent product launches hint that the public company wants to give teams more tools for building and prototyping apps, not just ideating over static concepts. Last year, it released Figma Make for creating web apps. This year, it integrated with tools like Codex and Claude Code, and rolled out its own agents.
SailPoint v 1. čtvrtletí zvýšil celkové ARR o 26 % na 1,163 mld. USD, tažené růstem tržeb z SaaS o 36 % na 781 mil. USD. AI funkce používá asi 10 % zákazníků.
Key Takeaways SailPoint's growth is increasingly SaaS-led as total ARR rose 26% to $1.163B in the fiscal first quarter.Non-human identities drove 40% of identity growth, while AI capabilities reached about 10% of customers.SailPoint still has about $350M of on-premise ARR to migrate, with only 10% expected in fiscal 2027. SailPoint (SAIL - Free Report) is trying to broaden its role in enterprise security as identity expands beyond employees to machines, contractors and AI agents. That shift gives SailPoint a larger opportunity, but it also makes execution more complicated. SaaS adoption, AI-related demand and on-premise migrations are all moving together, creating a growth story with timing risk.
SailPoint’s platform is built around identity governance, with Identity Security Cloud and IdentityIQ serving as its core offerings. The company helps enterprises manage lifecycle events, certify access, enforce least-privilege controls and analyze risk across complex systems.
The strategic role is getting broader. SailPoint now frames identity as a control plane for human and non-human identities, including machine identities and AI agents. That matters for large enterprises and government accounts that need auditable access controls across cloud, legacy and custom applications.
SAIL Growth is Being Led by SaaS ARRSailPoint’s growth engine is increasingly SaaS-driven. Total annual recurring revenue reached $1.163 billion in the first quarter of fiscal 2027, up 26% year over year, while SaaS annual recurring revenue rose 36% to $781 million.
SaaS represented 92% of net new annual recurring revenue in the quarter, compared with 69% a year earlier. Dollar-based net retention held at 113%, showing that existing customers continue to expand usage and add capabilities.
For second-quarter fiscal 2027, SailPoint expects revenues between $308 million and $312 million, indicating year-over-year growth of 17-18%. Adjusted earnings are expected to be between 7 cents and 8 cents per share for the second quarter of fiscal 2027.
SailPoint AI Push is Becoming More TangibleAI is no longer just a product narrative for SailPoint. Non-human identities accounted for 40% of identity growth in the first quarter of fiscal 2027 and represented 14% of all identities managed in the company’s cloud offering. Management said about 10% of customers had adopted AI capabilities. Agentic Fabric and related launches are aimed at discovering AI agents, mapping ownership, enforcing authorization, securing prompts and monitoring behavior. Okta (OKTA - Free Report) , Cisco Systems (CSCO - Free Report) and Microsoft (MSFT - Free Report) are other identity-focused companies investors may watch in this context.
Microsoft is SailPoint’s most significant competitor through its Microsoft Entra portfolio, which includes Entra ID, Identity Governance, Privileged Identity Management (PIM) and Conditional Access. Microsoft’s biggest advantage is its massive installed base of Microsoft 365 and Azure customers, allowing it to bundle identity governance with productivity, cloud and security offerings at attractive pricing.
Meanwhile, following the acquisition of Splunk and continued investment in cybersecurity, Cisco has strengthened its identity-focused security capabilities through Cisco Duo and its broader Zero Trust platform. Duo provides multi-factor authentication, device trust, adaptive access and identity verification, while Cisco integrates identity signals with networking and security operations.
Okta’s outlook is supported by steady demand for identity security, an expanding installed base, and rising attach of newer products such as Identity Governance, Privileged Access, and posture and threat capabilities. Management’s agent-focused roadmap and broad partner ecosystem keep Okta relevant as enterprises secure non-human identities and deploy AI workflows across multiple platforms.
SailPoint shares have dropped 18% year to date, outperforming Microsoft’s fall of 18.7%, while Okta and Cisco shares have returned 74.1% and 46.7%, respectively.
SAIL Stock’s Price Performance
Image Source: Zacks Investment Research
SAIL Migration Opportunity Still Has FrictionThe migration opportunity remains a major swing factor. SailPoint still has about $350 million of on-premise annual recurring revenue available for migration, and management has pointed to a typical 2-3 times uplift when customers move to SaaS and add capabilities.
The challenge is timing. These migrations can be complex, especially for large enterprises with legacy infrastructure and regulatory requirements. SailPoint expects only about 10% of its on-premise base to migrate in fiscal 2027, leaving a long runway but also making execution discipline important.
SailPoint Margins and Cash Flow Add SupportGrowth is not coming at the expense of operating discipline. Adjusted operating margin improved to 13.5% in the first quarter of fiscal 2027 from 10.2% a year earlier.
Cash generation also improved the setup. SailPoint delivered $38 million in operating cash flow and $33 million in free cash flow during the quarter. Management also raised fiscal 2027 targets for annual recurring revenue, revenues and adjusted operating margin.
ConclusionThe bottom line is that SailPoint has a credible growth story tied to SaaS adoption, AI identity governance and enterprise migrations. Still, the pace of on-premise conversions and the revenue-recognition effects of the SaaS shift keep the near-term setup balanced.
SAIL currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
JPMorgan čeká, že tržby SpaceX porostou o 91 % ročně do roku 2030, ale hlavním motorem má být AI infrastruktura, ne jen více startů raket. Banka vidí tržby 470 miliard USD v roce 2030.
The real headline may be the bank’s expectation that the company can grow revenue at a staggering 91% annual rate through 2030—a forecast that, according to JPMorgan, has surprisingly little to do with selling more rocket launches.
Instead, analyst Doug Anmuth argues launches are simply the foundation for a much bigger business.
The AI Story Hidden Behind the RocketsFor years, investors have viewed SpaceX primarily as a launch company powered by Falcon rockets and Starlink satellites.
JPMorgan believes that narrative is already becoming outdated.
Anmuth says “launch is SpaceX’s core competitive advantage that enables every other part of the business,” with rapid Starship reusability laying the groundwork for an AI infrastructure platform rather than simply a larger launch business.
By 2031, JPMorgan expects Starship launches to ramp from only a handful this year to roughly 5,000 annually, enabling SpaceX to deploy 75 gigawatts of orbital compute as it pursues an addressable market exceeding $28 trillion.
From Connectivity to AIThat shift fundamentally changes SpaceX’s financial profile.
JPMorgan projects revenue climbing from $19 billion in 2025 to $470 billion by 2030, while operating margins improve from negative 14% to roughly 50% over the same period. The driver isn’t simply more launch activity, but what the report describes as a business mix shifting from “Connectivity to AI, first terrestrial, and then orbital.”
Anmuth argues that transition justifies valuing SpaceX more like a next-generation AI infrastructure company than a traditional aerospace business.
Why Launch Still MattersIronically, the bullish AI thesis begins with rockets.
SpaceX has completed roughly 670 orbital launches with a 99%+ mission success rate and has launched more than 80% of all mass sent to orbit since 2023, according to JPMorgan. Those capabilities—and Starship’s rapid reusability—give the company a structural advantage that competitors cannot easily replicate.
That launch leadership, combined with what Anmuth calls SpaceX’s “extreme vertical integration,” enables the company to build not only rockets but also satellites, AI infrastructure and, eventually, orbital data centers faster and more cheaply than rivals.
For investors, that may be the biggest takeaway from JPMorgan’s initiation.
The firm’s $225 price target implies meaningful upside. But the more important bet is that SpaceX’s next decade won’t be defined by how many rockets it launches—it will be defined by what those rockets make possible.
Image via Shutterstock
Market News and Data brought to you by Benzinga APIs
I keep hitting the buy button on Apple (NASDAQ:AAPL | AAPL Price Prediction), and the July 30 earnings report is not slowing me down. Every payday, I add a few more shares. The reasons are boring, repeatable, and they stack in my favor over years, which is the profile I want in a core holding heading into retirement. Here is what keeps pulling me back.
A cash machine that pays me to wait Apple generated $111.48 billion in operating cash flow in FY25 and returned $90.71 billion to shareholders through buybacks that same year. In April, the board authorized another $100 billion repurchase program and raised the quarterly dividend 4% to $0.27. Total capital returned since the program began now exceeds $1 trillion. The 0.34% yield looks small in isolation, but paired with ROE of 171.4% and ROIC of 53.3%, I am fine with management compounding capital inside the business instead of mailing it out.
The Services engine keeps widening the moat Q2 FY26 revenue reached $111.18 billion, up 16.6% year over year, with iPhone at $56.99 billion and Services at an all-time record $30.98 billion. Services gross margin ran at 76.7% on a base of over 2.5 billion active devices. That is a high-margin annuity riding on hardware customers already own. Tim Cook described Apple Intelligence as “woven into the core of our platforms”, and MacBook Neo demand is running so hot he flagged the company was “supply constrained”. Greater China grew 28% in the March quarter. Management guided June-quarter revenue growth of 14% to 17% with gross margin of 47.5% to 48.5%. That is what the July 30 report will confirm.
An earnings track record I trust Apple has delivered nine consecutive beats, with the last quarter posting an EPS of $2.01 against a $1.94 estimate. In the 30 days after that May report, shares rose 10.75%, outpacing SPY by 6.09 percentage points. Over the past year the stock is up 45.86%, and over ten years it is up 1,313.91% on a split-adjusted basis. That is the kind of compounding I plan around.
The risk I actually respect China exposure and the supply chain keep me disciplined. Greater China revenue was $20.50 billion last quarter, and Cook warned that “significantly higher memory costs” will pressure the June quarter. Add the CEO handoff to John Ternus effective September 1, 2026 and the execution bar is real. My response: those memory costs are already baked into the 47.5% to 48.5% margin guide, and Ternus is a 25-year Apple veteran inheriting a roadmap Cook publicly called “incredible”.
Why the buy button stays active At a P/E of 40 on a business printing 26.9% net margins at a $4.53 trillion market cap, Apple looks pricey on the screen and reasonable on the cash it will send my account over the next decade. I plan to keep buying through July 30, and the quarter after that, and the one after that.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Apple didn't make the cut. Grab the names FREE today.
UBS uvedla, že růst tržeb App Store ve čtvrtletí končícím v červnu zpomalil na zhruba 3 % meziročně, v USA tržby klesly asi o 6 %. Analytici to spojují i s ochlazováním aktivity kolem generativní AI.
Apple Inc (NASDAQ:AAPL, XETRA:APC)'s App Store revenue growth slowed in the June 2026 quarter, according to an analysis by UBS, which tracked third-party App Store data from Sensor Tower.
UBS analysts wrote that the App Store recorded approximately 3% year-over-year growth on a reported basis during the quarter, while growth was around 2% on a foreign exchange-neutral basis. The firm noted that growth slowed by roughly 440 basis points compared with the prior quarter, despite only a slightly more challenging comparison period.
The US market was a key source of weakness, with App Store revenue declining approximately 6% year-over-year in the quarter, UBS wrote. In other regions, the App Store grew about 9% year-over-year on a reported basis.
UBS wrote that Apple’s September 2026 quarter will face an easier comparison period, with the year-over-year growth benchmark expected to be around 10%, approximately 270 basis points lower than the June quarter comparison.
The analysts maintained their June-quarter Services revenue estimate, forecasting growth of about 14.3% year-over-year, compared with consensus expectations of roughly 14.5%.
UBS wrote that the estimate remains unchanged despite potential downside risks from slower App Store growth, noting that Apple’s Services segment continued to show strength in the March 2026 quarter, when Services revenue increased about 16.3% despite App Store growth of roughly 8%.
UBS also flagged slowing growth in generative artificial intelligence-related activity, which it views as a contributor to App Store growth. The firm wrote that AI-related growth may be moderating due to tougher comparisons and increasing market saturation.
For valuation, UBS maintained a price target of $296 for Apple shares, based on a valuation multiple of 30 times its calendar 2027 earnings-per-share estimate of $9.86. UBS wrote that the valuation reflects balanced expectations for solid demand alongside uncertainty surrounding Apple’s artificial intelligence strategy.
Shares of Apple were little changed at $313 on Tuesday afternoon.
Meta Platforms v úterý rostla po zlepšení doporučení analytiků; Erste Group zvýšila doporučení na Buy a BNP Paribas potvrdila Outperform před výsledky za druhé čtvrtletí.
The gains came amid improving analyst sentiment and growing investor optimism over Meta’s long-term artificial intelligence monetization strategy.
Erste Group upgraded the stock to Buy from Hold, while BNP Paribas reiterated its Outperform rating ahead of second-quarter earnings.
BNP Paribas said Meta remains well-positioned to sustain revenue growth despite rising AI infrastructure spending and sees a potential future cloud offering as an additional long-term growth opportunity.
Analyst Outlook Ahead Of EarningsBNP Paribas reiterated its Outperform rating and $955 price forecast on Meta ahead of the company’s expected earnings release in the last week of July.
Senior analyst Nick Jones said investors are likely to focus on Meta’s capital spending plans, AI product development, a potential cloud offering and subscription adoption trends.
The analyst expects second-quarter revenue growth to slow from prior quarters because of temporary factors but believes the company can maintain long-term top-line momentum.
Revenue And Earnings ExpectationsBNP Paribas said Meta’s valuation suggests investors remain cautious about earnings growth, the scale of AI investments, returns on those investments, competition in artificial intelligence and the broader macroeconomic environment.
Jones said investors are expecting second-quarter revenue growth of 27% to 29% year over year, compared with the consensus estimate of 27%. He also expects GAAP diluted earnings per share above $7.40, versus the Street consensus of $7.19.
For the third quarter, BNP Paribas believes investors are looking for revenue guidance of $62 billion to $64 billion, compared with the consensus estimate of $63.2 billion.
AI Spending Remains In FocusThe analyst also expects Meta to raise its 2026 capital expenditure outlook by at least $10 billion from its current $125 billion to $145 billion range as higher component costs continue to inflate AI infrastructure spending.
Despite slowing user growth as Meta’s platforms approach saturation, BNP Paribas said engagement remains a key strength. The firm estimates Meta accounts for more than 40% of time spent across major social media platforms, nearly double that of its next-largest competitor. That, it said, should support continued growth in revenue per daily active person.
BNP Paribas expects Meta to fund its elevated AI investments through stronger monetization of AI features, advertising market share gains, subscription revenue and the optionality of a future cloud offering.
Meta Platforms Technical AnalysisMeta is trading about 5.4% above its 20-day simple moving average and slightly above its 50-day moving average. However, the stock remains below both its 100-day and 200-day moving averages, suggesting the longer-term trend has yet to turn positive.
Momentum indicators have improved. The moving average convergence divergence (MACD) remains above its signal line, indicating selling pressure has eased.
Even so, the broader trend remains cautious. The 20-day moving average is still below the 50-day average, while the 50-day average remains below the 200-day average following a death cross that formed in December 2025.
Technical analysts are watching resistance near $643, close to the 200-day moving average. Initial support sits around $595 near the 50-day moving average.
Earnings Remain The Next Major CatalystAttention is now shifting to Meta’s expected second-quarter earnings report, estimated for July 29, 2026, which could shape the stock’s next move.
Wall Street expects earnings per share of $7.18, up from $7.14 a year earlier. Revenue is projected to increase to $60.22 billion from $47.52 billion.
The stock trades at roughly 21.8 times earnings and carries a consensus Buy rating. The average analyst price forecast stands at $826.88. Recent analyst actions include:
Erste Group upgraded the stock to Buy on Tuesday. Wells Fargo maintained an Overweight rating and raised its price forecast to $767 on July 2. RBC Capital Markets reiterated its Outperform rating with an $810 price forecast on June 1. Meta Platforms Price ActionMETA Stock Price Activity: Meta Platforms shares were up 1.42% at $608.83 at the time of publication on Tuesday, according to Benzinga Pro data.
Image via Shutterstock
Market News and Data brought to you by Benzinga APIs
Meta představila nový model Muse Image pro generování obrázků a chce jím přilákat tvůrce i inzerenty. Model bude zdarma v aplikaci a na webu Meta AI, ve WhatsApp přímých zprávách a v Instagram Stories, ale pokročilé funkce budou součástí placených předplatných. Později v roce má být dostupný také na Facebooku a Messengeru i v dalších částech Instagramu a WhatsApp.
Meta on Tuesday released Muse Image, a new artificial intelligence model for creating images as the company seeks to attract creators and advertisers to its offerings.
Originally codenamed Mango, the AI technology marks the second major release from Meta Superintelligence Labs led by Alexandr Wang, who oversaw the April unveiling of the Muse Spark large language model that succeeded the company's previous Llama family of models.
Muse Image will be available for consumers to access for free via the Meta AI app and site, WhatsApp direct messages and Instagram Stories. Power users and creators must sign up for one of Meta's new monthly subscription plans that debuted in May to create many AI-generated images and access certain features. If users hit their free limit, they can purchase a Meta One subscription or wait until their limit resets, the company said.
Muse Image will also power advertiser-specific, image-generation tools as part of Meta's AI-powered Advantage Plus service that lets brands more easily develop ad creative for their marketing campaigns and automate certain tasks. Meta said it's been working with businesses and advertisers as part of debuting Muse Image.
"Muse Image brings native reasoning to the creative process to adjust elements, swap styles, and create variations based on the advertiser's creative, resulting in high-quality, on-brand ad variations with fewer iterations," the company said in a blog post for businesses. "In the coming weeks, advertisers and agencies can expect to see image variants powered by Muse Image."
Read more CNBC tech newsChinese lidar maker with Nvidia ties accused of being cyber risk for U.S.China's Alibaba bans Anthropic AI for employees after 'distillation attack' accusationSpaceX President Gwynne Shotwell to donate stock to Trump AccountsMicrosoft cuts 4,800 jobs, as Xbox unit downsizes and plans to spin off four gaming studiosThe new image-generation model and efforts to monetize it show how Meta is trying to expand from its core business of online advertising and generate new revenue sources tied to its hefty spending on AI-related infrastructure.
OpenAI and Alphabet got a head start over Meta in offering similar image-generation models, with Google's Nano Banana becoming a hit with consumers when it was released last fall.
Meta also revealed internal benchmark tests showing Muse Image trailing OpenAI's latest GPT Image 2 model but beating the Nano Banana 2 model in tasks like editing both single and multiple images.
The social media giant has previously used third-party AI models like Midjourney and Black Forest Labs to power various image and video generation features within its Meta AI app and site. The company said it plans to use its new AI model to reduce reliance on similar third-party technologies.
Meta also plans to release an AI video generation model dubbed Muse Video at a later date, adding in a technical blog that it "offers competitive performance in prompt adherence, visual fidelity, and temporal consistency."
Muse Image will be available on Facebook and Messenger as well as more areas within the Instagram and WhatsApp services later in the year.
Nvidia je jen necelých 6 % pod hranicí 5 bilionů USD, když po pondělním uzavření měla tržní hodnotu asi 4,74 bilionu USD. V prvním fiskálním čtvrtletí jí tržby meziročně vzrostly o 85 % na rekordních 81,6 miliardy USD.
Only one company in history has ever been worth $5 trillion: Nvidia (NVDA +0.55%) itself. The chipmaker first crossed the mark last October, then slipped back below it. After closing Monday at about $195.55 per share, the chipmaker carried a market value of roughly $4.74 trillion. That leaves it less than 6% below a milestone no other business has ever touched.
So how close is Nvidia, exactly, and what would it take to get there? The math is simple, and the underlying business is firing on all cylinders.
Image source: Getty Images.
The number that gets it there With about 24.2 billion shares outstanding, Nvidia crosses $5 trillion at a share price of roughly $206. From Monday's close near $195.55, that's a gain of a little more than $10 per share, or about 5.5%. Put another way, Nvidia needs to add about $260 billion in market value. That is a rounding error for a company this size, though it still exceeds the entire market value of most companies in the S&P 500.
With that said, shares are down slightly on Tuesday, so the stock will need to add a bit more than that, but the point remains: it's extremely close.
For a stock that has climbed more than 350% over the past three years on the back of the AI boom, a move that small is nothing. Nvidia has gained that much in a single day more than once. So the $5 trillion mark is less a distant summit than a step the stock could clear on any morning of good news.
What could close the gap, or widen it The case for Nvidia getting there soon rests on the same thing that got it here: extraordinary demand for its chips. In its fiscal first quarter (the period ended April 26, 2026), revenue rose 85% year over year to a record $81.6 billion. Data center revenue climbed 92% to $75.2 billion. Management then guided for about $91 billion in revenue this quarter, another sharp step up.
"The buildout of AI factories -- the largest infrastructure expansion in human history -- is accelerating at extraordinary speed," said Nvidia CEO Jensen Huang in the company's fiscal first-quarter earnings release. As long as that spending holds, the earnings power behind the stock keeps growing.
But the gap can widen just as easily, and it's widening today. Case in point: Tuesday morning's sell-off, part of a broader memory-led chip sell-off after Samsung's preliminary record quarterly profit forecast, which still wasn't enough for Wall Street, stoked fresh worries about how long the AI boom can last. That's the near-term headwind. Sentiment toward the whole sector has turned jumpy, and Nvidia rarely trades apart from it.
Meanwhile, the longer-term risks are familiar ones. Nvidia's biggest customers, including Amazon and Alphabet, are designing their own chips to lean less on it, which could soften Nvidia's pricing power over time. And the semiconductor industry has always moved in cycles, so today's demand surge probably won't run this hot forever.
It's also worth putting the company's sheer size in perspective. At about $4.7 trillion, Nvidia is already worth more than the entire annual output of most of the world's economies, and the last leg to $5 trillion alone would add about the market value of a large-cap company in a single move. That scale is a reminder of how much optimism is already reflected in the price.
Today's Change
(
0.55
%) $
1.08
Current Price
$
196.63
What the milestone actually means At about 30 times trailing earnings and less than 20 times forward earnings, Nvidia isn't priced like a stock that has run out of room. Indeed, that forward multiple is actually significantly cheaper than the broader market -- a reflection of the extraordinary trajectory of the company's underlying earnings. The real question, therefore, isn't the valuation so much as the durability of the demand behind it. If AI spending stays strong, the stock has a clear path well past $5 trillion. If today's sell-off marks the start of a genuine cooling in that spending growth, the milestone could stay out of reach for a while.
Either way, I'd treat the number itself as a curiosity, not a catalyst. What matters for investors is what happens to demand for its chips, not which side of a round number the stock happens to sit on.
Certara integruje Nvidia BioNeMo Agent Toolkit do své platformy AI pro vývoj léčiv. Silo Pharma prostřednictvím své dceřiné společnosti QwikAgents vstoupila do programu Nvidia Developer Program.
Certara is integrating Nvidia’s BioNeMo Agent Toolkit into its AI-driven drug development platform, while Silo Pharma’s subsidiary, QwikAgents, has joined the Nvidia Developer Program to strengthen its AI agent capabilities.
• Nvidia stock is gaining positive traction. Why are NVDA shares climbing?
Certara Integrates Nvidia BioNeMo Into AI Drug Development PlatformCertara said it is partnering with Nvidia to advance its open, integrated AI platform by combining its scientific software, regulatory expertise, and proprietary datasets with AI-first, agentic frameworks.
Under the collaboration, the Nvidia BioNeMo Agent Toolkit will become one of several agentic frameworks available within Certara’s platform.
The toolkit is designed to turn AI agents into autonomous life sciences researchers by providing access to Nvidia’s life sciences technology stack while complementing Certara’s biosimulation models, regulatory expertise and scientific teams.
AI Agents Target Drug Development WorkflowsAccording to Certara, specialized AI agents will analyze scientific models, datasets and domain expertise across multiple stages of drug development.
The company said these agents can support tasks such as optimizing dosing strategies using systems pharmacology models, analyzing clinical datasets, simulating patient and clinical trial scenarios, evaluating ADMET properties, assembling regulatory-ready evidence and assessing early-stage drug discovery hypotheses.
Certara added that the technology is intended to enhance the work of biosimulation experts and scientific teams by accelerating insight generation while keeping scientists at the center of decision-making.
Silo Pharma Subsidiary Joins NVIDIA Developer ProgramSeparately, Silo Pharma announced its wholly owned subsidiary, QwikAgents, has joined the Nvidia Developer Program.
The company said QwikAgents’ platform automates complex workflows using autonomous AI agents capable of reasoning, taking action and interacting with enterprise systems.
The platform also incorporates persistent memory, intelligent routing across multiple large language model providers, browser automation and secure data management to support scalable AI-driven operations.
Silo Pharma said participation in the Nvidia Developer Program will provide QwikAgents with access to Nvidia’s AI software ecosystem, development frameworks, technical training and optimization resources.
The company expects those resources to help accelerate platform enhancements as it expands AI agent capabilities for enterprise customers.
CERT/SILO Stock Price Activity: Certara shares were down 0.63% at $7.09, Silo Pharma shares were down 2.10% at $6.09 at the time of publication on Tuesday, according to Benzinga Pro data.
Image via Shutterstock/ Alexander56891
Market News and Data brought to you by Benzinga APIs
Netflix od 3. srpna přidá krátká videa od vydavatelů včetně Variety, BuzzFeed Studios, Condé Nast, Hearst Magazines, People Inc., Tastemade a dalších značek Penske Media PMX, pro předplatitele v USA, Kanadě, Británii, Irsku, Austrálii a na Novém Zélandu. Firma tím testuje zájem o levnější formáty mimo seriály a filmy.
Netflix is again experimenting with new types of content on its streaming service, as the binge model has grown dated. After expanding its service to include live content, video games, and, more recently, video podcasts, the streamer is now adding video content from publishers such as BuzzFeed Studios, Condé Nast, Hearst Magazines, People Inc., Tastemade, and various Penske Media PMX brands, like Variety, THR, Billboard, Eater, Rolling Stone, and IndieWire.
Starting August 3, Netflix will offer video content from these publishers to subscribers in the U.S., Canada, the U.K., Ireland, Australia, and New Zealand, according to Netflix and other reports released on Tuesday by Netflix’s deal partners like Variety, Billboard, THR, Rolling Stone, and others.
The new videos will vary widely in length — some run just two to three minutes, while others stretch past 20, the partners said.
For Netflix, the deal is a low-risk way to test whether its audience has an appetite for the kind of content that’s typically native to the web, such as news, lifestyle, how-tos, and other short-form formats that tend to be cheaper and faster to produce than a scripted series. If it works, Netflix could eventually build similar content in-house, though the company hasn’t said that’s the plan.
The lineup will include both licensed archival and ongoing series coming to Netflix, including BuzzFeed Celeb’s “30 Questions” and “Tasty”; Vanity Fair’s “Lie Detector Test” and “How Well Do They Know Each Other?”; AD’s “Walking Tour”; Elle’s “Where Is the Lie?”; Harper’s Bazaar’s “Burning Questions”; Billboard’s “24 Hours”; People’s “My Life in Pictures”; Travel + Leisure’s “Travel Unfiltered”; Tastemade’s “Struggle Meals”; and more.
Netflix says other publishers will be added over time.
The announcement follows a Bloomberg report this week that found that Netflix is struggling to retain fans between the first and second seasons of top shows. That trend has reportedly worried executives, though it’s largely explained by familiar culprits: high cancellation rates, long gaps between seasons, and inconsistent quality. The report suggests that Netflix is also facing a shift in consumer viewing habits, which sees the streamer now competing with YouTube and TikTok — arguably as much as it competes with traditional TV networks now.
To court viewers drawn to short-form video, Netflix already added a TikTok-style feature called “Clips” that lets users scroll through short snippets from its library. But where Clips is designed to funnel viewers toward longer shows and movies, these new publisher deals go the other direction, bringing short-form content onto the platform in its own right.
“Members don’t just want to watch a show or film and move on — they want to keep exploring the stories and personalities they love long after the final credits roll. These partnerships help us deepen fandom and create more ways for members to carry those stories with them throughout their day,” stated John Derderian, Netflix VP of Animation Series + Kids & Family TV, who is overseeing this project.
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.
Sarah has worked as a reporter for TechCrunch since August 2011. She joined the company after having previously spent over three years at ReadWriteWeb. Prior to her work as a reporter, Sarah worked in I.T. across a number of industries, including banking, retail and software.
You can contact or verify outreach from Sarah by emailing [email protected] or via encrypted message at sarahperez.01 on Signal.
Bank of America dnes dosáhla nového historického maxima nad 60 USD za akcii před výsledky za 2. čtvrtletí. Wall Street čeká tržby 30,58 miliardy USD a EPS 1,14 USD.
Bank of America (BAC +0.23%), the second-largest bank in the U.S. by assets, hit a new all-time high today, with the stock topping $60 per share.
Many large bank stocks have had a good year thus far, particularly the investment banks, which have benefited from some massive artificial intelligence initial public offerings.
However, some of the money-center banks, such as Bank of America, have not performed as well. The stock is up about 7.5%, trailing the broader market S&P 500 Index and the Nasdaq Bank Index.
Here’s what it means ahead of second-quarter earnings.
Image source: Getty Images.
Overcoming challengesBank of America is viewed as a high-quality banking franchise, with the number one consumer bank, and strong franchises in investment banking, trading, wealth management, and commercial lending.
The Iran war, which has led to higher inflation and higher bond yields, may have derailed some of its momentum because investors are now worried about persistent inflation and whether the Federal Reserve will need to raise interest rates to ensure price stability.
Higher rates can put pressure on the credit profiles of consumers and businesses and stymie lending and investment banking activity.
Bank of America has also long grappled with balance sheet issues that stem from the pandemic, when the bank loaded up on low-yielding, long-duration bonds.
Today's Change
(
0.23
%) $
0.14
Current Price
$
60.04
The bank has nearly $915 billion in bonds still yielding 2.77%, which is depressing earnings somewhat.
Furthermore, the bank locked in nearly $515 billion of bonds into its held-to-maturity folder that are still carrying an unrealized $81 billion loss.
While Bank of America will be able to hold these bonds to maturity and avoid taking these paper losses, it’s still a drag on earnings. Higher rates would likely exacerbate the paper losses as well.
The good news is that Bank of America is just coming off one of its strongest quarters in a while in the first quarter of 2026, having delivered a 16% return on tangible common equity (ROTCE).
Net interest income, the spread revenue banks make on their lending and bond portfolios after paying funding costs, has been building in recent quarters.
Investment banking should be strong as well, given that Bank of America served as one of the five main bookrunners on the massive Space Exploration Technologies (SPCX 5.80%) IPO.
How investors should think about earningsBank of America will report its second-quarter earnings next week on July 14.
Wall Street analysts’ consensus estimates suggest the bank will report revenue of $30.58 billion and earnings per share of $1.14. That implies slight growth from the first quarter, but certainly nothing heroic.
This is not a huge surprise because large banks are mature companies at this point.
Investors will need to see the company beat estimates for the stock to rise, and credit quality, investment banking fees, and net interest income trends will also be top of mind for the market.
With Bank of America trading at a price-to-tangible-book ratio over 2x and near 10-year highs, earnings misses or minor concerns could lead to selling pressure, given the elevated valuation.
BAC Price to Tangible Book Value data by YCharts
That said, I still think Bank of America is a decent long-term investment.
Continued improvements in ROTCE can lead to a higher valuation over time, and eventually the bond portfolio will run off, boosting the company’s earnings power.
JPMorgan Chase má před výsledky za 2. čtvrtletí odhad zisku na akcii 5,49 USD při tržbách 48,71 miliardy USD. Akcie jsou letos výše o 4,9 % a blíží se rekordu.
JPMorgan Chase & Co (NYSE:JPM) is scheduled to report second-quarter earnings before the open on Tuesday, July 14, kicking off earnings season alongside several other major banks. According to Zacks Research, analysts expect earnings of $5.49 per share on revenue of $48.71 billion, representing year-over-year growth of 10.7% and 8.5%, respectively.
Options traders are pricing in a relatively modest post-earnings reaction. The options market implies a next-day move of 4.7%, though that is nearly double JPM's average post-earnings move of 2.4% over the last eight quarters. The bank has closed lower after each of its last four earnings reports, including a 4.2% drop in January.
JPMorgan stock is bucking today's broad-market weakness as chip stocks pressure the major indexes, though it has pared earlier gains, last seen up 0.2% at $338.31. The shares are on track for a fourth straight gain and are moving back toward their June 25 record high of $343.34. Longer term, there is notable support at the 320-day moving average. Year to date, the equity is up 4.9%.
Analyst sentiment could leave room for upgrades. Of the 26 brokerages covering JPMorgan, 12 carry a "buy" or "strong buy" rating, while 14 maintain "hold" recommendations, with no "sell" ratings on the books. With the shares trading just below record territory, investors will be looking to see if the bank's results and outlook can support another run at fresh highs.
Shanghai Disneyland je nejvýdělečnější mezinárodní park Disney: od otevření přinesl mateřské společnosti zisk 516,2 milionu USD. V roce 2024 navíc návštěvnost stoupla o 5 % na 14,7 milionu.
Shanghai Disneyland is Disney's highest earning international international resort. (Photo by VCG/VCG via Getty Images)
VCG via Getty Images
Disney has revealed that the total profit payout it receives from one of its theme parks outside the United States passed the $500 million mark last year making it the studio's highest-earning international outpost based on its share of the bottom line.
Surprisingly, the accolade doesn't go to Disneyland Paris even though it generates more revenue than any other Disney park outside the U.S. Instead, Shanghai Disneyland takes the crown of paying more of its profit to its parent than any other international Disney park with the total coming to an eye-watering $516.2 million since the doors to the resort swung open a decade ago.
The sprawling site on the eastern edge of Shanghai encompasses two hotels, a lake, an entertainment district and a fairytale-themed park which Disney's former chief executive Bob Iger famously described as being "authentically Disney, distinctly Chinese." There is good reason for this. Instead of creating a carbon-copy of Disney's American theme parks, its designers, who are known as Imagineers due to their imaginative use of engineering, tailored the Shanghai site to the local market. Everything was customized, from the park's layout and attraction lineup right down to its wide range of Chinese food.
It has cast a powerful spell as Shanghai Disney welcomed its 100 millionth guest in November last year and it isn't stopping there. At an event marking its tenth anniversary last month the resort announced that it is building a third on-site hotel, called the Disney Enchanted Star, with a fourth property also under development to cater for the surging demand.
According to the latest data from the Themed Entertainment Association (TEA), attendance at Shanghai Disneyland rose 5% to 14.7 million in 2024 driven by the opening of a new land themed to the Oscar-winning computer animated movie Zootopia. This made it the world's fifth most-visited theme park but the magic touch it has on Disney's bottom line has remained a closely-guarded secret. Until now.
MORE FOR YOU
Shanghai Disneyland has surged in popularity since the opening of its 'Zootopia' land. (Photo by Tang Yanjun/China News Service/VCG via Getty Images)
China News Service via Getty Images
Disney doesn't list the results of individual parks in its filings in the United States and China's companies register isn't public. However, recent filings for an obscurely-named company in the United Kingdom have lifted the curtain on the fortunes of Shanghai Disneyland.
Unlike Disney's theme parks in the United States, the resort is a public-private partnership between the media giant and China's state-owned Shanghai Shendi Group.
Disney only has a 43% stake in the company which owns the resort itself with the remainder in Shendi's hands. In contrast, Shendi is a minority shareholder in the resort's management company which is controlled by Disney through its 70% stake. In return, Disney receives royalties as well as a management fee based on the operating performance of the resort.
Disney’s shares in the resort and the management company are held by a wholly-owned subsidiary called WD Holdings (Shanghai) in Burbank, California. It pays dividends from its profits to the Disney companies which directly own it. Precisely 47% of WD Holdings is owned by The Walt Disney Company Limited in London which files publicly-available financial statements. Its latest set of filings were released recently and show that its dividends from WD Holdings began in 2019 and peaked at $57.7 million (£43.1 million) last year as I recently revealed in the Daily Mail.
This only represents 47% of the dividend so the full amount for 2025 is $122.7 million (£91.7 million) as the chart below shows. The dividend hit its lowest level in 2021 when it crashed by 60.3% to $25.9 million (£18.9 million) the midst of the pandemic. It has surged since then, thanks partly to the opening in December 2023 of the new Zootopia land. Is the first and only theme park area based on the film which was a huge hit in China.
Dividends paid by Shanghai Disneyland's holding company
MSM
A massive 23.1% of Zootopia's $1 billion box office was generated in China while a sequel last year did even better. It hauled in $630 million from China making it the highest-grossing Hollywood film in Chinese history. The theme park land capitalizes on this.
Home to a cutting-edge roving simulator ride, it is filled with brightly-colored buildings which have robotic replicas of the characters from the film peering out of their windows. Disney put more than 260 Zootopia products on sale in the park and created themed food for its restaurants. More than 532 tons of its pink paw-shaped pawpsicles alone have been sold. It has given a glow to Disney's bottom line.
'Zootopia' fans can try real-life pawpsicles in Shanghai Disneyland. (Photo by Tang Yanjun/China News Service/VCG via Getty Images)
China News Service via Getty Images
Three of its four international parks either don’t pay a dividend or only pay small sums. Disney doesn’t own its resort in Tokyo, which is run by specialist leisure operator Oriental Land Company (OLC). In return for licensing its intellectual property, OLC pays Disney royalties but not a a share of its profits. Disneyland Paris pays both but the only time it has paid out a share of its profits was in 1993 when its dividend yielded just $10.2 million (FF56.6 million) for Disney as I recently reported in The Guardian.
Likewise, Hong Kong has one of the smallest Disney parks and in 2024, following the opening of a land themed to the Oscar-winning film Frozen it made its highest-ever profit of $107.8 million (HK$838 million) which is lower than the dividend its counterpart in Shanghai paid out last year.
Shanghai's total profit payout of $516.2 million (£392.8 million) is the highest of any of Disney's international parks and doesn't even include any royalties as they are paid directly to one of its U.S. subsidiaries so they aren't shown on the U.K. filings. The total dividend for last year will actually be even higher than the amount reported in the financial statements as Disney shuffled its Shanghai shares into yet another subsidiary mid-way through 2025 and the filings for this entity are confidential.
Disney’s theme parks produced 57% of its $17.6 billion operating income and nearly 40% of its $94.4 billion revenue in 2025 which explains why the company is doubling down on them. It has earmarked $60 billion for investment in its theme park division by 2033 with a new Spider-Man themed roller coaster coming to Shanghai and a second park widely expected to get the green light as this report explained.
Nevertheless, in line with its ownership stake, it is understood that Disney covered around 43% of the estimated $5.5 billion construction cost of its resort in Shanghai so despite banking a string of blockbuster dividends from it, the studio is still waiting for its happy ending.
Bank of America obnovila pokrytí Adobe s ratingem Underperform a cílovou cenou 190 USD, protože podle ní generativní AI oslabuje konkurenceschopnost firmy. Akcie přesto v úterý vzrostly asi o 4,6 %.
Adobe Inc. ADBE shares rose about 4.6% on Tuesday even after Bank of America reinstated coverage of the software company with an Underperform rating.
The brokerage argued that generative artificial intelligence is weakening Adobe's competitive position despite the stock trading near the lower end of its historical valuation range.
Bank of America set a price target of $190, valuing the company at seven times its projected 2027 enterprise value to free cash flow (EV/FCF), below the roughly 9.7-times average multiple for a broader group of software companies.
The brokerage said Adobe's valuation alone is not sufficient to support a more constructive investment stance as the company faces increasing competition from AI-native products.
Bank of America analysts, led by Tal Liani, said the key issue facing Adobe is whether the company can accelerate growth in an AI-driven software market.
The analysts wrote that the central question is whether Adobe "can reaccelerate growth in the age of AI."
While Adobe has seen adoption of its AI offerings, the brokerage said those products have yet to generate a meaningful financial contribution.
According to the report, AI-first annual recurring revenue (ARR) currently accounts for less than 2% of Adobe's total ARR.
The bank forecasts total revenue growth slowing from 10.5% in 2025 to 8.8% in 2027, with "no clear path to near-term reacceleration."
The report also noted that AI-related competitive risks vary across Adobe's customer base.
Casual users and non-professional creators are viewed as more vulnerable because AI-generated content can often replace paid subscriptions.
Professional and enterprise customers are expected to remain more resilient because they require precision and integrated workflows.
However, the analysts cautioned that "not all professional users need the full Adobe workflow," leaving some professionals and single-application users exposed to lower-cost AI alternatives.
Leadership transition and product pressures remain in focusBank of America also highlighted challenges facing Adobe Stock, the company's marketplace for images and videos.
Management has said Adobe Stock has declined for two consecutive quarters, although it did not disclose specific figures.
The brokerage said the weakness reflects the broader risk that free or inexpensive AI tools could reduce demand for Adobe's higher-margin legacy offerings while limiting future seat expansion.
The analysts also pointed to recent executive changes as another source of uncertainty.
They said the simultaneous departures of CEO Shantanu Narayen and CFO Dan Durn "heightens risk around strategy, continuity, and leadership stability" as Adobe navigates its AI transition.
Although the bank expects Adobe to maintain strong profitability, including a free cash flow margin approaching 39% by 2028, it believes there is "limited multiple expansion without clear evidence of AI monetization and growth acceleration."
Historical data also suggests that buying large pullbacks in Adobe shares has produced inconsistent results.
Since 2010, the stock has experienced 12 declines of at least 20% within a 30-day period.
Only six of those events generated positive returns over the following year. The median one-year return after those declines was negative 4%, while investors experienced a median maximum drawdown of 17% before any recovery.
Despite that track record, Adobe's underlying financial performance remains solid.
The company reported 11.5% revenue growth over the last 12 months, with a three-year average growth rate of 11%. It also generated an operating cash flow margin of 41.6%, highlighting strong profitability and cash generation.
Creative Freemium monthly active users increased from 50 million to 90 million year over year.
Adobe currently trades at a price-to-earnings ratio of about 12, compared with roughly 25 for its peer benchmark, although Bank of America maintained that stronger evidence of AI-driven growth will be needed before adopting a more positive view on the stock.
Snowflake hlásí rychlejší adopci AI Data Cloudu, který nyní využívá více než 13 600 účtů. Firma čeká ve 2. čtvrtletí fiskálního roku 2027 růst produktových tržeb o 30 % na 1,415–1,420 miliardy USD.
Key Takeaways Snowflake AI adoption continues to grow across thousands of customer accounts. SNOW expanded enterprise AI partnerships with Thomson Reuters and Sanofi. Snowflake forecasts 30% year-over-year product revenue growth for fiscal Q2 2027. Snowflake (SNOW - Free Report) is benefiting from the accelerating adoption of its AI Data Cloud, which is fundamentally transforming how organizations leverage data and artificial intelligence to drive productivity and innovation. The rapid adoption of new AI-driven products like Snowflake Intelligence and Cortex Code (CoCo) remains noteworthy.
In the fiscal first quarter, Snowflake delivered more than 20% more product capabilities than last year. This includes new features in CoCo and Snowflake Intelligence. These products are seeing the fastest uptake in Snowflake’s history, with CoCo already in use by more than 7,100 accounts and Snowflake Intelligence more than doubling quarter over quarter. New customers such as Holiday Inn Club Vacations and Houzz selected Snowflake as the foundation for their data and AI transformation initiatives. The adoption of Snowflake AI capabilities continued to expand, with more than 13,600 accounts now leveraging these solutions.
Further expanding its AI footprint through partnerships, in June 2026, Snowflake announced that Thomson Reuters is building its enterprise AI and data platform on the Snowflake AI Data Cloud to deliver trusted, governed intelligence at scale. The collaboration enables faster analytics, modernizes legacy systems with Snowflake CoCo and supports enterprise AI innovation using Snowflake Cortex.
Snowflake also announced that Sanofi launched its “Concierge for Field,” an AI agent built with Snowflake Cortex AI to help sales representatives prepare for physician visits in seconds. The collaboration also supports Sanofi's broader deployment of AI agents across R&D, procurement, IT, HR and field sales to accelerate innovation and drug development.
Snowflake’s growing customer base, combined with its rapid product innovation, positions the company for continued upside. Snowflake expects fiscal second-quarter 2027 product revenues in the range of $1.415-$1.420 billion, implying 30% year-over-year growth.
SNOW Suffers From Stiff CompetitionSnowflake is facing stiff competition from the likes of major players like Oracle (ORCL - Free Report) and Amazon (AMZN - Free Report) , which are also expanding their footprint in the AI space.
Amazon’s AI initiatives gained significant momentum during the first quarter of 2026. Amazon’s cloud computing platform, Amazon Web Services’ chips business, including Graviton, Trainium, and Nitro, exceeded a $20 billion annual revenue run rate and is growing triple-digit percentages year over year.
Oracle’s expanding portfolio has been noteworthy. In June 2026, Oracle introduced Oracle OPERA Cloud Assistant, a suite of AI-powered capabilities built into OPERA Cloud that automates guest room assignments, generates AI-driven rate descriptions, supports multilingual operations across 230 countries and territories and gives hotel staff real-time operational guidance.
SNOW’s Share Price Performance, Valuation, and EstimatesSnowflake shares have gained 19.5% in the year-to-date period, outperforming the broader Zacks Computer & Technology sector’s increase of 14.7%. The Internet Software industry has declined 11.2% in the same time frame.
SNOW Stock Performance
Image Source: Zacks Investment Research
Snowflake stock is trading at a premium, with a forward 12-month Price/Sales ratio of 13.55X compared with the Internet Software industry’s 3.78X. SNOW has a Value Score of F.
SNOW's Valuation
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for SNOW’s fiscal 2027 earnings is pegged at $1.96 per share, which has been unchanged over the past 30 days. The figure indicates a 56.80% year-over-year increase.
Snowflake currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Key Takeaways LMND benefits from AI-led underwriting, claims automation and rising multi-policy adoption.In-force premium reached $1.33 billion, marking the 10th consecutive quarter of accelerating growth.Lemonade's reinsurance strategy, improving margins and positive free cash flow support its profitability path. Shares of Lemonade (LMND - Free Report) have gained 88.7% in the past year, outperforming the industry’s growth of 8.2%.
Strong premium growth, improving underwriting performance and continued progress toward profitability have driven the stock. Growth in in-force premium, expanding multi-policy adoption, Lemonade auto and its AI-driven platform have supported revenue growth and operating efficiency. While sustained premium growth, improving profitability and higher customer retention could support further upside, the stock's premium valuation may limit multiple expansion. The company has surpassed earnings estimates in each of the last four quarters, with an average of 25.8%.
Lemonade’s shares have outperformed its peers, including EverQuote Inc. (EVER - Free Report) and Hamilton Insurance (HG - Free Report) , which have gained 7% and 63.4%, respectively, while Root Inc. (ROOT - Free Report) has lost 46.5% in a year.
1-Year Price Performance: LMND, EVER, HG, ROOT & Industry
Image Source: Zacks Investment Research
Growth Estimates for LMNDThe Zacks Consensus Estimate for the company’s 2026 and 2027 earnings indicates a 23.6% and 49% year-over-year increase, respectively.
The consensus estimates for 2026 and 2027 revenues suggest year-over-year improvements. LMND has a Growth Score of A.
Muted Analysts' Sentiment on LMNDThe Zacks Consensus Estimate for LMND's 2026 and 2027 earnings has witnessed southbound movement, respectively, in the past 30 days.
Image Source: Zacks Investment Research
Factors in Favor of LMNDLemonade's AI-driven operating model enhances underwriting, pricing, claims automation and customer service, supporting a scalable, low-cost business model. The company's operating efficiency continues to improve, with in-force premium per employee exceeding $1 billion in the first quarter of 2026, nearly tripling over the past four years. Meanwhile, underwriting performance continues to improve, with the gross loss ratio declining despite winter storm-related losses. Disciplined underwriting and favorable prior-year reserve development drove a 159% increase in gross profit in the first quarter, reinforcing the company's path toward sustained profitability.
Pet Insurance and Lemonade Auto continue to post strong growth, while rising multi-policy adoption improves customer retention and lifetime value, supporting long-term premium growth. Its multi-product strategy enhances customer lifetime value through cross-selling opportunities while supporting a recurring, subscription-like revenue model. Strong customer retention and engagement continue to fuel growth, with management forecasting 32% revenue growth for the second quarter and 33% for full-year 2026.
Lemonade’s in-force premium (IFP) reached $1.33 billion at the end of first-quarter 2026, marking the 10th straight quarter of accelerating growth. This momentum reflects the growing contribution of its AI- and automation-driven platform, which enables efficient scaling. Customer growth and higher premiums per customer continue to drive premium expansion. Management has outlined a long-term goal of increasing IFP to $10 billion.
A major strength of the business is its reinsurance strategy, which shifts a substantial portion of claims risk to partners, helping stabilize earnings and reduce volatility. Strong premium growth and a lower reinsurance ceding rate enable the company to retain a larger share of premiums, contributing to revenues. Management expects the favorable reinsurance structure to continue supporting results through at least mid-2026.
Although profitability remains a challenge, margins are improving, free cash flow has turned positive, and management expects EBITDA profitability by the fourth quarter of 2026. Lemonade exited the first quarter with approximately $1.1 billion in cash and investments and raised its full-year 2026 outlook, reflecting confidence in sustained premium growth, improving profitability and continued business momentum.
Risks for LMNDLemonade's premium valuation remains a key concern. It trades at a 12-month trailing price-to-book ratio of 11.67X, well above the industry average of 2.96X and its three-year median of 3.97X. The elevated valuation leaves limited room for multiple expansion.
The company's results also remain exposed to catastrophe losses. Although weather-related claims were manageable in the first quarter, severe storms, hurricanes, wildfires or other catastrophic events could materially increase claims costs, pressure underwriting margins and lead to earnings volatility.
Additionally, Lemonade continues to invest heavily in customer acquisition. Sales and marketing expenses rose more than 50% year over year in the first quarter of 2026. These could weigh on margins if customer acquisition and retention fail to deliver adequate returns. While marketing efficiency remains strong, maintaining it will be important for long-term profitability.
ConclusionLemonade is well-positioned for long-term growth, supported by strong premium expansion, an AI-driven operating model and improving profitability. Its diversified product portfolio, disciplined underwriting and reinsurance strategy strengthen its competitive position. Its favorable growth estimates and positive free cash flow are other positives.
However, given a premium valuation and catastrophe exposure remain key risks, it is wise to adopt a wait-and-see approach for this Zacks Rank #3 (Hold) insurer. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Micron klesl o 7,7 % poté, co Samsung oznámil silné výsledky a zároveň uvedl, že buduje masivní továrny na polovodiče, které mohou zvýšit nabídku pamětí.
After starting the week strong, Micron (MU 5.87%) stock tumbled an unlucky 7.7% through 10:55 a.m. ET.
Blame Samsung for that.
Image source: Micron.
Korea sends the semi market South South Korean technology giant Samsung reported its Q2 2026 earnings last night. The news was objectively good -- sales up 28% sequentially, and more than double last year's Q2 revenue. Operating profit surged 19-fold, rising to $58.4 billion.
And yet Samsung stock sold off 7% today. Why?
The results beat analyst forecasts, but in a quirk of this overheated artificial intelligence-fueled stock market, investors expected Samsung to beat expectations. This triggered a "buy the rumor, sell the news" phenomenon in which investors sold Samsung stock despite its numbers being better than "expected" -- and despite Samsung confirming computer memory prices are still rising, and its profits are continuing to climb.
Today's Change
(
-5.87
%) $
-57.83
Current Price
$
926.92
What this means for Micron stock So how does all of this affect Micron, and why is it sparking a sell-off today?
Well, consider: Samsung is the world's biggest supplier of DRAM computer memory, used to make high-bandwidth memory (HBM) used in AI data centers. It's got a 38% share of the global market. SK Hynix, No. 2 in DRAM, is No. 1 in HBM with more than a 50% market share. Micron makes both NAND and DRAM memory, and its DRAM share is smaller -- about 22%, still enough for third place.
If things stay as they are, with prices rising and demand insatiable, Micron should do quite well. The problem is alongside announcing powerful profits, Samsung also said that it is building "massive semiconductor fabrication plants" to add supply to the market -- growing its market share, eating away at Micron's, and potentially closing the supply demand gap in the process.
This, in a nutshell, is why Micron stock is selling off today.
Rich Smith has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Micron Technology. The Motley Fool has a disclosure policy.
SK Hynix plánuje vstup na Nasdaq a může získat až 28 miliard USD nového kapitálu na expanzi a nákup zařízení. Firma ovládá asi 60 % trhu s HBM, který je klíčový pro AI.
SK Hynix's Nasdaq listing can not only reset the AI memory trade but also accelerate it. The company is weaponizing Wall Street to ensure it retains its leadership position in the hottest market since the AI boom started booming.
With control of approximately 60% of the high-bandwidth memory (HBM) market, which is critical for advanced computing, the opportunity is for investors to gain share in a leading memory pure-play at a discount to its peers. Estimates have SK Hynix Korean listing trading at approximately 8x forward earnings compared to Micron’s NASDAQ: MU 13.5x, suggesting an easy double-digit upside immediately upon listing.
While the upside potential for SK Hynix's U.S. listingis robust, there are a few things for investors to consider, the primary one being volatility. The listing will include the issuance of new shares, representing approximately 2.5% of the existing share count, which will provide a slight headwind for price action.
Get Micron Technology alerts:
The offset will likely be massive institutional backing, with several high-profile firms committing to large stakes. Institutional backers include Situational Awareness Partners, an investment firm founded by a former OpenAI researcher, and Coatue Management, a U.S.-based firm focused on technology.
SK Hynix Throws Down the Gauntlet, Micron Will RespondSK Hynix's U.S. listing is expected to raise as much as $28 billion in new capital. The money will be used to accelerate expansion plans and buy new equipment, both critical to meeting demand and maintaining product timelines.
The company is strengthening ties with NVIDIA NASDAQ: NVDA, ensuring it can deliver next-gen products when needed, including HBM4. HBM4 is critical to AI, as it breaks down the memory wall by enabling skyrocketing bandwidth with low power consumption, doubling the speed of HBM3 versions, and offering approximately 75% more memory capacity. The impact on AI will be tremendous.
Catalysts for SK Hynix's share price include the robust demand for HBM products, which are sold out through 2027, and pricing power. HBM memory pricing is up by high double digits, underpinning growth for SK Hynix and Micron, and is expected to remain hot for the foreseeable future. SK Hynix removed pricing caps that had been in place, allowing it to capture maximum upside while the HBM shortage persists.
Micron Technology Today
MU
Micron Technology
$922.66 -62.09 (-6.31%)
As of 02:45 PM Eastern
This is a fair market value price provided by Massive. Learn more.
52-Week Range$103.38▼
$1,255.00Dividend Yield0.07%
P/E Ratio20.90
Price Target$1,263.76
Micron, however, is not sitting idly by, allowing SK Hynix to gain share. It is actively expanding its own manufacturing capacity and HBM4 technology, including a major HBM4 hub in Japan, and realigning its die process to more closely align with NVIDIA standards so it can capture a larger share.
The likely outcome is that Micron breaks SK Hynix's near-monopoly with NVIDIA while cementing its position in the industry. Micron is also capitalizing on its unique position as the U.S.'s only domestic-based memory manufacturer, expanding facilities in Idaho and New York.
Micron May Experience Headwinds—Sell-Side Data Says Buy the DipWhile Micron’s outlook is equally bullish, there is potential for its share price action to lag SK Hynix, at least in the near- to mid-term. The risk is that investors will take profits and reduce their holdings of MU in order to shift capital into SK Hynix. In this scenario, the best-case is that MU’s stock price moves sideways within a range near existing highs, while the worst-case is that it experiences a more robust correction than it already has. Down more than 20% from its post-earnings highs as of early July, Micron’s share price could shed another 30% before hitting solid support.
The caveat is that sell-side interest, as reflected in the analysts and institutional data, remains very bullish on Micron, with a triple-strength tailwind in place. MarketBeat data reveal 38 analysts covering the name, a 92% Buy-side bias in the Buy consensus, and more than 35% upside potential relative to early-July support targets, with coverage rising, sentiment firming, and price targets trending higher over the near-, mid-, and long-term. It is not the consensus figures that matter but the trends, which are leading to the high range and suggest more than 100% is still ahead.
Micron’s stock price action reflects market strength, with a bullish MACD convergence. The MACD, or moving average convergence/divergence, measures market strength and momentum and, in this case, shows a strong, strengthening market more likely to retest its recent highs and move higher than to continue moving lower. The only question is the timing, and that may be by year’s end. Upcoming catalysts include Micron’s fiscal Q4 earnings release in September, along with reports from NVIDIA and Advanced Micro Devices NASDAQ: AMD, which are expected to confirm that AI demand continues to grow.
Should You Invest $1,000 in Micron Technology Right Now?Before you consider Micron Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Micron Technology wasn't on the list.
While Micron Technology currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Intuitive Surgical uvedla, že apendektomie má v USA adresovatelný trh zhruba 300 000 zákroků ročně. První analýzy podle firmy ukázaly, že da Vinci překonává laparoskopii v několika měřeních.
Key Takeaways ISRG sees about 300,000 U.S. appendectomies as an addressable market still being evaluated.Intuitive Surgical said early analyses showed da Vinci outperformed laparoscopy on multiple measures.ISRG expects appendectomy to lift procedure volume, though lower reimbursement may weigh on revenue mix. Although the appendectomy is in its early stages, it is emerging as one of the newest growth avenues for Intuitive Surgical’s (ISRG - Free Report) robotic surgery franchise. During the first quarter of 2026, the company highlighted continued strength in U.S. general surgery, with cholecystectomy and appendectomy procedures collectively growing 31%.
The growth was primarily supported by increasing use of da Vinci systems during after-hours and weekend surgeries. Management also noted that appendectomy represents an addressable market of roughly 300,000 annual procedures in the United States, though it is still evaluating what proportion of that market is realistically suitable for robotic surgery.
A key catalyst for broader adoption is the emergence of encouraging clinical evidence. Management stated that several institution-level analyses showed da Vinci surgery delivering superior outcomes across multiple functional measures compared with conventional laparoscopy. While these findings remain preliminary and require validation through larger clinical studies, they provide an important foundation for expanding robotic use in a procedure traditionally dominated by laparoscopic techniques.
However, reimbursement remains a meaningful constraint. Intuitive Surgical acknowledged that appendectomy is a relatively quick procedure with comparatively low reimbursement, limiting the immediate economic incentive for hospitals to adopt robotics broadly. The company believes stronger clinical evidence will be necessary before robotic appendectomy gains wider acceptance despite its promising outcomes.
From an investment perspective, appendectomy is likely to drive higher procedure volume, but the impact on margins may not be material in the near term. Higher procedure counts could increase utilization of Intuitive Surgical’s installed base, particularly during evenings and weekends, supporting recurring instrument and accessory revenues.
The lower reimbursement profile suggests the procedure may generate lower revenue per case than more complex robotic surgeries, creating a potential mix headwind. Even so, successful expansion into high-volume general surgery procedures aligns with Intuitive Surgical’s long-term strategy of broadening robotic adoption beyond its traditional specialties, reinforcing sustainable procedure growth over time.
Peer UpdatesZimmer Biomet (ZBH - Free Report) is expanding its robotic surgery opportunity by broadening both procedural indications and platform capabilities rather than relying solely on knee arthroplasty. The company has fully commercialized ROSA Shoulder, enabling robotic assistance for both anatomic and reverse shoulder replacements through glenoid reaming and humeral resection. The company is already developing a second-generation system with tighter integration into the broader ROSA digital ecosystem.
Beyond shoulders, Zimmer is preparing the semi-autonomous mBos robotic platform for a 2027 launch, positioning it as a faster, more accurate and easier-to-use system that could democratize robotic orthopedics across additional procedures. Coupled with investments in more than 200 robotic clinical specialists and continued growth of ROSA and TMINI, the company is building a multi-platform robotics portfolio designed to unlock new procedure categories and expand its addressable market.
Stryker (SYK - Free Report) is widening Mako's growth runway by transforming the platform from a knee-and-hip robot into a multifunctional orthopedic ecosystem. Following record first-quarter Mako installations, the company plans a full Mako 4 launch for shoulder surgery in mid-2026 while adding advanced hip and revision hip procedures that simplify technically demanding operations.
Management believes these new indications will increase robot utilization and ultimately drive demand for additional systems as hospitals require greater robotic capacity. Stryker is also targeting surgeons who have been hesitant to adopt full robotics through the new Mako RPS handheld system, particularly in ambulatory surgery centers, thereby expanding its customer base beyond traditional Mako users. The company indicated that more robotic indications are under development, reinforcing its strategy of creating new market opportunities through continuous procedural expansion rather than relying only on implant growth.
ISRG’s Price Performance, Valuation and EstimatesShares of ISRG have lost 23.6% so far this year compared with a 12.4% decline of the industry.
Image Source: Zacks Investment Research
From a valuation standpoint, Intuitive Surgical trades at a forward price-to-earnings ratio of 39.08X, above the industry average. But, it is still lower than its five-year median of 69.80X. ISRG carries a Value Score of D.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Intuitive Surgical’s 2026 earnings implies a 16.6% rise from the year-ago period’s level.
Image Source: Zacks Investment Research
The stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
MercadoLibre dál roste, tržby meziročně stouply o více než 30 % na 29 miliard USD. Investoři ale řeší nižší ziskovost, protože čistá marže klesla z 10,5 % ve 4. čtvrtletí 2024 na 6,4 % ve 4. čtvrtletí 2025.
When investors think about MercadoLibre (MELI +1.11%), they typically think of one of the world's best growth stories. The company has spent years building Latin America's leading e-commerce marketplace, while simultaneously growing Mercado Pago into one of the region's largest digital financial platforms.
Yet, despite another year of impressive operating results, the stock hasn't rewarded investors as it once did. So what's happening?
The answer isn't slowing growth. It's that investors have become increasingly concerned about MercadoLibre's cost of maintaining that growth.
Image source: Getty Images.
Growth isn't the problem By almost every operating measure, MercadoLibre is executing exceptionally well. Revenue has grown by more than 30% year over year to $29 billion, supported by healthy increases in gross merchandise volume, unique buyers, and payment volume.
Payments platform Mercado Pago is attracting new users while expanding deeper into lending, investments, and digital banking. Meanwhile, the company is investing billions of dollars to strengthen its logistics network and payments infrastructure across Brazil, Mexico, and Argentina.
These aren't the numbers of a business that's losing momentum. Instead, they reinforce the same long-term investment thesis that has driven MercadoLibre's success for years: Latin America's digital economy remains underpenetrated, and the company continues to strengthen its leadership position.
If growth were the only thing investors cared about, MercadoLibre's stock would probably be performing much better.
Today's Change
(
1.11
%) $
19.99
Current Price
$
1,825.67
Investors are becoming less tolerant of lower margins Instead, the market's attention has shifted to profitability.
During 2025, MercadoLibre increased spending on logistics, lowered free-shipping thresholds in Brazil, and leaned more heavily on promotions to defend its competitive position. Those investments helped drive higher engagement and transaction volumes, but they also weighed on operating margins. For perspective, net margin has fallen from 10.5% in the fourth quarter of 2024 to 6.4% in the fourth quarter of 2025.
That has created a different debate among investors. The question is no longer whether MercadoLibre can continue growing. It's whether that growth is becoming more expensive.
This distinction matters because companies can grow revenue for years while delivering disappointing shareholder returns -- if profitability fails to keep pace. In short, investors have become increasingly focused on whether MercadoLibre can eventually convert its scale into stronger earnings and free cash flow.
Competition has intensified in recent years Part of that concern stems from a more competitive landscape.
Shopee, a subsidiary of Sea Limited, has continued expanding aggressively in Brazil through shipping subsidies, attractive seller incentives, and low prices. Another newcomer, Temu, a subsidiary of PDD Holdings, has reset consumer expectations by offering ultra-cheap products shipped directly from China. On the fintech side, Nu Holdings is competing for consumers' wallets and financial relationships.
None of these companies individually poses a threat to MercadoLibre's leadership. Collectively, however, they force MercadoLibre to invest more aggressively to defend its ecosystem. For perspective, the company aims to invest $11 billion in its Brazilian market in 2026, up 50% from 2025.
That has important implications for investors. Competition doesn't have to reduce MercadoLibre's market share to affect the business. Just defending its leadership may require permanently higher logistics spending, more promotions, or lower seller fees, which could impact the company's long-term profitability.
What does it mean for investors? MercadoLibre remains one of the strongest businesses in Latin America. Its marketplace, logistics network, and fintech ecosystem reinforce one another, creating competitive advantages that few companies in the region can match.
But the stock is no longer being judged solely on growth. Investors also want proof that MercadoLibre can translate its expanding ecosystem into improving profitability. Until that happens, the stock may continue to experience volatility, even as the underlying business scales. Long-term investors need to be aware of this.
Strategy prodala část bitcoinů poprvé od roku 2022, aby financovala dividendy na preferenční akcie. Po prodeji držela 843 775 bitcoinů a 2,55 miliardy USD v hotovosti.
What Strategy’s July 6 Filing Actually Says About Its First Major Bitcoin Sale Since 2022
The filing is specific. The coins went in two tranches: 1,363 bitcoin between June 29 and June 30, then 2,225 between July 1 and July 5 at an average of roughly $60,773. The proceeds funded quarterly dividends on four preferred series, STRF, STRE, STRK and STRD, plus the semi-monthly dividend on STRC.
The uncomfortable number is the cost basis. Strategy’s average purchase price is about $75,476 a coin, so it sold below cost, realizing a loss to raise cash. After the sale it held 843,775 bitcoin and $2.55 billion in cash.
Why A Small Sale Is A Big SignalFor years the model was simple: issue securities, buy bitcoin, never sell. This sale confirms that has changed. Strategy adopted a framework that permits sales to meet obligations — the reason is the preferred stack: those dividends, roughly $1.6 billion a year, are a standing cash call the software business cannot cover, and the sale recasts the dividend-and-capital-structure story around the coins.
The Two SidesThe bull case is that the sale is tiny, roughly 0.4% of holdings, the balance sheet still carries $2.55 billion in cash, and the same preferreds raised the capital that bought the bitcoin in the first place. This is not a solvency event.
The Bottom LineThe disclosure is small in size and large in signal: Strategy’s dividend obligations now shape its treasury decisions. For anyone following MSTR, the variable to track is the preferred dividend run-rate against cash and the company’s ability to issue equity, because that, more than the bitcoin price alone, now decides whether Strategy is a buyer or a seller.
Disclosure: The author holds no position in Strategy and no position in bitcoin.
Benzinga Disclaimer: This article is from an unpaid external contributor. It does not represent Benzinga’s reporting and has not been edited for content or accuracy.
Market News and Data brought to you by Benzinga APIs
Cloudflare vzrostl v úterý o 7 % poté, co Scotiabank zvýšila rating na Sector Outperform ze Sector Perform a cílovou cenu na 300 USD. Banka vidí rostoucí roli firmy v AI infrastruktuře.
Cloudflare Inc. NET shares climbed 7% on Tuesday after Scotiabank upgraded the cloud infrastructure and cybersecurity company, citing growing confidence in its long-term role in artificial intelligence infrastructure and raising its price target on the stock.
The brokerage upgraded Cloudflare to Sector Outperform from Sector Perform and increased its price target to $300 from $225, pointing to multiple catalysts that it believes could drive stronger revenue growth over the coming quarters.
Shares of Cloudflare rose after the analyst report, adding to investor optimism surrounding the company's expanding role in AI infrastructure and developer tools.
Scotiabank analyst Patrick Colville said Cloudflare's Workers platform is increasingly becoming a preferred infrastructure layer for AI-generated, or "vibe coded," applications, including OpenAI Codex Sites and Lovable.
"We upgrade our rating on the common shares of Cloudflare to Sector Outperform and lift our price target to $300," Colville said.
After spending the past 4+ weeks doing a deeper dive on Cloudflare's opportunity, we feel convinced that the time is now to own NET as: (1) Workers is becoming the default infrastructure for vibe coded applications – including OpenAI Codex Sites and Lovable, a dynamic we think is underappreciated by investors; (2) Traffic trends, which typically precede revenue by 3 quarters are inflecting due to agentic AI and will set Cloudflare up nicely to beat and raise Street numbers by ~5pp in 2H26, (3) Cloudflare is winning the best of the best AI-native customers, which validates their architecture and provides a long runway for growth.
According to Scotiabank, these developments are not yet fully reflected in investor expectations and could become an increasingly important driver of Cloudflare's future growth.
The brokerage also pointed to the company's ability to attract leading AI-native customers, saying this validates its technology platform and supports a longer runway for expansion.
Scotiabank said Cloudflare's traffic growth has historically preceded revenue growth by approximately three quarters and noted that those trends are now accelerating as demand for agentic AI applications increases.
The firm believes the improvement in traffic could allow Cloudflare to outperform Wall Street expectations by roughly five percentage points during the second half of 2026.
The report argues that stronger traffic trends, combined with growing adoption of AI-focused applications, position the company for improved financial performance over the coming quarters.
The analyst note follows Cloudflare's July 1 launch of Monetization Gateway, which expands its existing Pay Per Crawl service into Pay Per Use through the open x402 protocol.
The initiative is designed to allow website owners to charge AI agents for access on a per-use basis, supporting what the company describes as the emerging agentic web.
The feature remains in an early-access and waitlist phase.
While acknowledging that Cloudflare continues to trade at a premium valuation, Scotiabank said the company's long-term opportunity in AI infrastructure is becoming increasingly clear.
The brokerage argued that the combination of growing AI adoption, improving traffic trends and continued product development supports a more constructive outlook for the stock despite its elevated valuation.
Cloudflare trades at a forward P/E of 204.19, according to data from stockanalysis.
Key Takeaways Cameco halted Cigar Lake mining after Orano's McClean Lake mill's sulfuric acid plant shut down.Operations at McClean Lake are expected to resume in two weeks, with no current impact on 2026 guidance.Cigar Lake produced 19.1 million pounds in 2025, with Cameco's share at 10.4 million pounds. Cameco Corporation (CCJ - Free Report) has temporarily suspended operations at Cigar Lake mine, citing operational issues at Orano’s McClean Lake mill, where Cigar Lake ore is processed. The mill is expected to resume operations in two weeks, and the company does not currently anticipate any impact on its 2026 production guidance for Cigar Lake. However, any prolonged outage at the McClean Lake mill could prompt a reassessment of that outlook.
The disruption stems from problems at the mill's sulfuric acid plant, which was forced to shut down for repairs. Orano is working to restore the acid plant and is also evaluating alternative sources of sulfuric acid while it awaits replacement parts. With limited ore storage capacity at Cigar Lake, mining activities had to be stalled until sufficient acid was available to allow milling to resume at McClean Lake.
Cameco increased its ownership stake in Cigar Lake to 57.418%. Located in northern Saskatchewan, Canada, Cigar Lake is widely recognized for its exceptionally high-grade ore body and long reserve life, making it one of the most valuable uranium mines globally.
In 2025, the mine produced 19.1 million pounds, with Cameco’s attributable share at 10.4 million pounds. For 2026, Cigar Lake is expected to produce between 17.5 million and 18.0 million pounds on a 100% basis. Based on Cameco's previous ownership interest of 54.547%, its attributable production was projected at 9.5-10.0 million pounds. Following the recent increase in ownership, the company is expected to update its attributable production outlook to reflect the same.
This is the second operational disruption Cameco has faced this year. In May, the company temporarily suspended operations at its McArthur River mine and Key Lake mill after severe flooding in northern Saskatchewan caused a partial collapse of the Smoothstone River Bridge, a critical transportation route used to deliver supplies to the sites. Cameco quickly established an alternative logistics route, restoring the flow of essential materials and enabling both operations to return to full production within a short period.
Despite the interruption, Cameco maintained the 2026 guidance for uranium production of 14.0-16.5 million pounds from the McArthur River and Key Lake operations, with its attributable share at 10-11.5 million pounds. The company expects consolidated attributable uranium production of 19.5-21.5 million pounds in 2026.
CCJ’s Price Performance, Valuation & EstimatesCameco shares have gained 30% in a year compared with the industry’s 22.6% growth. Uranium peers Energy Fuels Inc. (UUUU - Free Report) and Uranium Energy (UEC - Free Report) have gained 120.4% and 57%, respectively.
Image Source: Zacks Investment Research
CCJ stock is trading at a forward price-to-sales multiple of 16.67X compared with the industry’s 5.42X. Energy Fuels is currently trading at a forward price-to-sales ratio of 18.59X and Uranium Energy is trading at a loftier 59.76X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Cameco’s earnings for fiscal 2026 indicates year-over-year growth of 17.5%. The same for 2027 implies growth of 58.8%.
Image Source: Zacks Investment Research
While the consensus estimate for 2026 earnings has moved down over the past 60 days, the same for 2027 has remianed unchanged, as shown in the chart below.
Image Source: Zacks Investment Research
The company currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Akcie Lucid Group klesly až o 10 % poté, co Rivian oznámil emisi akcií a investoři začali více řešit kapitálové potřeby Lucid. Společnost má stále likviditu zhruba 4,7 miliardy USD.
Shares of luxury electric vehicle (EV) maker Lucid Group (LCID 8.86%) are tanking today. Investors can thank a rival EV maker for the move. Rivian Automotive announced a capital raise, and that has investors focusing on Lucid's capital needs, too.
Lucid shares dropped as much as 10%, and remained lower by 8.6% as of 12:15 p.m. ET.
Image source: The Motley Fool.
Lucid's capital source Lucid could arguably be out of business had it not been for its close relationship with the Saudi Arabian sovereign wealth fund. The Public Investment Fund (PIF) is Lucid's largest shareholder and has provided capital in several investment rounds in the past few years.
Most recently, Lucid withdrew $500 million in capital from the PIF-provided Delayed Draw Term Loan (DDTL). As of the end of Q1, there was still $2 billion remaining in undrawn capacity. After Rivian announced a common stock offering last night that should raise about $1.5 billion, investors may be scrutinizing Lucid's capital needs more closely.
Today's Change
(
-8.86
%) $
-0.59
Current Price
$
6.07
To be clear, the company still has a large cushion of available capital. After fresh capital was raised after the end of Q1, Lucid's total liquidity was approximately $4.7 billion. The company needs to steer investor focus to the underlying business now. Its new, luxury Gravity SUV needs to show some strong sales numbers when Lucid reports Q2 on Aug. 4.
That, along with any progress on its self-driving technology, could drive the share price higher in the coming months.
Howard Smith has positions in Lucid Group and Rivian Automotive. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Rocket Lab oznámil plánovanou akvizici Iridium Communications v hotovostně-akciové transakci za 8 miliard USD. Transakce má posílit konkurenci pro Starlink od SpaceX.
Space Exploration Technologies (SPCX 5.36%), also known as SpaceX, went public last month. While its overall business is unprofitable, the area doing well is connectivity and the internet, which includes its Starlink subsidiary. It provides satellite internet service.
Competition, however, may be ramping up in that space, particularly with another rocket company, Rocket Lab (RKLB 7.93%), announcing a major acquisition. And that could be a big problem for SpaceX stock.
Image source: Getty Images.
Rocket Lab to buy Iridium Communications Last month, Rocket Lab announced plans to acquire Iridium Communications in a cash-and-stock transaction worth $8 billion, calling it a "historical deal" for its business. The move will make the company vertically integrated, combining the launch capabilities of Rocket Lab, which is also involved in satellite manufacturing, with the satellite communications network that Iridium possesses. Together, Rocket Lab says it will be a "space powerhouse primed for growth." The deal is expected to close in the middle of next year.
The strategy is similar to SpaceX's and could result in greater competition for Starlink, which is the company's big moneymaker thus far. And it's not only Rocket Lab that Starlink has to potentially worry about, as there are other companies showing interest in this space as well; tech giant Amazon is also launching Leo in the near future, which is its own satellite internet provider.
Today's Change
(
-5.36
%) $
-8.59
Current Price
$
151.83
Is SpaceX stock in trouble? SpaceX's connectivity segment may not attract as much investor interest as artificial intelligence (AI) or space, but that's the driving force behind the company's business these days. During the first three months of the year, the connectivity segment accounted for nearly 70% of the top line, which totaled $4.7 billion. It was also the only segment that wasn't in the red, with an operating profit of just under $1.2 billion.
An influx of competition could pose greater risks for SpaceX down the road, as it could slow Starlink's growth. If that happens, SpaceX, which is already unprofitable and burning through billions in cash, may require even greater cash infusions to continue investing in its AI and space objectives.
SpaceX is already a risky stock given its inflated valuation, and with more competitors potentially challenging Starlink in the future, it may have even more to prove. Investors are clearly having second thoughts about the space stock as it's now trading around the levels it was at when it first went public, and it may be due for an even greater decline in the future. This is a stock I'd tread carefully with.
PPL plánuje do roku 2029 investice za 23 mld. USD, které mají podpořit růst regulované aktivní základny, 10,3% roční růst rate base a horní hranici 6–8% růstu EPS.
Key Takeaways PPL's balanced energy portfolio supports stable cash flows and future earnings growth. PPL is evaluating nuclear and pumped-storage hydro projects for reliable, carbon-free power.PPL plans $23B in investments through 2029 to drive rate base growth and EPS gains. PPL Corporation (PPL - Free Report) benefits from a diversified energy portfolio, reducing fossil fuel dependence and generating stable cash flows through regulated utility operations. Its Kentucky operations include a balanced mix of coal, natural gas, hydro and solar generation, while its regulated utilities in Pennsylvania and Rhode Island provide reliable electricity and natural gas delivery services. This balanced approach allows PPL to support decarbonization without sacrificing a dependable electricity supply, creating a strong foundation for future earnings growth.
The company is also evaluating advanced nuclear technology with X-energy and a 266-megawatt pumped-storage hydro project with Rye Development to support future demand for reliable, carbon-free electricity. If approved, these projects could expand PPL's regulated asset base and strengthen long-term earnings growth.
The company's portfolio benefits from rising electricity demand driven by AI data centers and industrial expansion. Its Pennsylvania segment registered nearly 28.3 gigawatts (GW) of potential data center demand, while Kentucky's development pipeline totals 12.9 GW, largely driven by data center projects.
PPL's planned $23 billion investment through 2029 will modernize infrastructure, expand clean energy generation, support 10.3% annual rate base growth and drive upper-end 6-8% EPS growth. The company's diversified utilities, capital investments and balanced energy portfolio support steady earnings growth and long-term shareholder value.
Balanced Energy Mix Supports Utility GrowthA balanced mix of regulated, renewable and natural gas generation supports rising electricity demand while ensuring grid reliability. This diversified portfolio reduces fuel price risk, supports stable earnings and positions utilities for long-term growth through cleaner and more resilient power generation.
Xcel Energy (XEL - Free Report) benefits from a balanced energy portfolio, expanding wind, solar, nuclear, natural gas and battery storage. It is strengthening generation and grid infrastructure to reliably meet rising data center and electrification demand.
NextEra Energy, Inc. (NEE - Free Report) benefits from a diversified generation mix led by renewable energy, alongside natural gas, nuclear power and other energy sources, supporting reliable operations, lower emissions and long-term earnings growth.
PPL’s Earnings EstimatesThe Zacks Consensus Estimate for 2026 and 2027 earnings per share indicates a year-over-year increase of 7.73% and 8.13%, respectively.
Image Source: Zacks Investment Research
Debt to CapitalPPL's debt-to-capital ratio currently stands at 57.40%, lower than the electric power industry’s 60.71%.
Image Source: Zacks Investment Research
PPL’s Stock Price PerformanceIn the past month, the company’s shares have risen 4.2% compared with the industry’s 4.5% growth.
Insulet v 1. čtvrtletí 2026 zvýšil výnosy o 30,1 % v konstantní měně, tažené růstem Omnipod o 33 % v konstantní měně. Firma zároveň zvýšila výhled výnosů na rok 2026.
Key Takeaways Insulet is positioned for growth as Omnipod 5 gains users across Type 1 and Type 2 populations. PODD's Omnipod revenues rose 33% in constant currency in Q1 2026, with Omnipod 5 now in 19 countries. Competition, SG&A investments and raw material and shipping costs could pressure PODD's margins. Insulet (PODD - Free Report) is well poised for growth in the upcoming quarters, owing to its strong momentum for the Omnipod 5 automated insulin delivery (AID) system for both Type 1 and Type 2 populations. The company is strongly executing against its long-term priorities to drive penetration, deepen competitive advantage, unlock new opportunities and scale profitably. However, macroeconomic pressures and intense competition could pose headwinds for Insulet’s operations.
In the past year, this Zacks Rank #3 (Hold) stock has lost 46.9% compared with the industry’s 27.7% decline. The S&P 500 composite has returned 23.6% in the same time frame.
The developer, manufacturer and distributor of insulin delivery systems has a market capitalization of $16.21 billion. The company’s estimated long-term earnings growth rate of 22.2% is well ahead of the industry’s 12.5% growth. PODD’s earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 16.2%.
Let us delve deeper.
Upsides for InsuletOmnipod 5 Gains Market Share: Omnipod 5 remains differentiated as a fully disposable, tubeless AID system that is expanding its installed base across both the U.S. and international markets. In first-quarter 2026, total company revenues grew 30.1% in constant currency, driven by Omnipod revenue growth of 33% in constant currency.
Management noted that its global customer base grew nearly 25% year over year, driven by higher new customer starts and retention trends consistent with the prior year. In the United States, growth included greater seasonality tied to deductible resets, but new customer starts improved through the quarter and into early second quarter. Internationally, growth continues to be supported by new customer starts and the conversion from Omnipod DASH to Omnipod 5, with Omnipod 5 now available in 19 countries.
Progress With Strategic Actions: Insulet is focused on driving growth in the global automated insulin-delivery market by expanding sensor connectivity and enhancing the Omnipod 5 experience. In the first quarter of 2026, the company completed a limited U.S. launch of Omnipod 5 integrated with Abbott Laboratories’ FreeStyle Libre 3 Plus and plans a broader rollout of the Libre 3 Plus integration and its latest algorithm update in the coming weeks.
Image Source: Zacks Investment Research
The company also enrolled the first participant in the EVOLVE pivotal study, which is intended to support a 510(k) filing in 2027. Supporting these initiatives, management raised its 2026 outlook, forecasting total company revenue growth of 21-23% and Omnipod revenue growth of 22-24%, while maintaining expectations for adjusted EPS growth of more than 25% for the year.
What Ails Insulet?Tough Competitive Pressure: Insulet competes against large, established diabetes device companies and newer entrants offering pumps, smart pens, and other insulin delivery approaches. As AID adoption expands globally, management expects competition to increase, which can raise commercial spending requirements and heighten payer negotiations.
In the first quarter of 2026, SG&A expense increased 21.7% year over year as Insulet invested in sales force expansion, demand generation and customer experience programs. Over time, competitive intensity can reduce revenue growth durability or limit the pace of operating margin expansion, which is mentioned in 2026 guidance.
Economic Uncertainty and Supply Exposure: Insulet operates in a global healthcare supply chain that remains exposed to geopolitical and macro uncertainty. Management cited incremental raw material and shipping costs tied to the ongoing conflict in the Middle East as an offset to its 2026 margin outlook. These factors may lengthen sales cycles, increase cost variability and reduce visibility into achieving the company’s 2026 operating-margin expansion target.
PODD Stock Estimate TrendThe Zacks Consensus Estimate for Insulet’s 2026 earnings per share has remained unchanged at $6.46 in the past 30 days.
The Zacks Consensus Estimate for the company’s 2026 revenues is pegged at $3.31 billion, implying a 22.2% rise from the year-ago reported number.
Key PicksSome better-ranked stocks in the broader medical space are Globus Medical (GMED - Free Report) , Integra LifeSciences (IART - Free Report) and Phibro Animal Health (PAHC - Free Report) .
Globus Medical has an earnings yield of 5.5%, well ahead of the industry’s negative 3% yield. Its earnings surpassed estimates in each of the trailing four quarters, the average surprise being 26.3%. The company’s shares have rallied 43.8% against the industry’s 4.8% decline over the past year.
GMED carries a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Integra LifeSciences, carrying a Zacks Rank #2 at present, has an earnings yield of 16% against the industry’s negative 3% yield. Shares of the company have gained 22.8% compared with the industry’s 4.8% growth. IART’s earnings topped estimates in each of the trailing four quarters, the average surprise being 16.8%.
Phibro Animal Health, carrying a Zacks Rank #2 at present, has an earnings yield of 9.2% compared with the industry’s 2.8% yield. Shares of the company have climbed 43.1% against the industry’s 27.9% decline. PAHC’s earnings beat estimates in each of the trailing four quarters, the average surprise being 16.3%.
HCA v 1. čtvrtletí zvýšila kapitálové výdaje o 12,9 % na 1,1 miliardy USD a rozšířila kapacitu nemocnic i pohotovostí. Schválila také projekty za 5,5–6 miliard USD na další růst během 24 až 30 měsíců.
Key Takeaways HCA expanded sites of care, hospital beds and emergency room capacity in first-quarter 2026.HCA approved $5.5-$6 billion in capital projects to add beds and ER capacity over 24 to 30 months.HCA reaffirmed 2026 guidance as patient trends improved after early-quarter weather and seasonal pressures. HCA Healthcare, Inc. (HCA - Free Report) is making significant investments to expand its healthcare network, reinforcing capacity growth as a core component of its long-term strategy. Despite short-term pressure on patient volumes, it continues to add hospital beds, expand emergency room capacity and selectively acquire outpatient healthcare assets to meet future demand. In the first quarter of 2026, capital expenditures rose 12.9% year over year to $1.1 billion. During the quarter, it expanded its sites of care by more than 4%, increased hospital bed capacity by nearly 1% and added 4% to emergency room capacity.
The strategy extends beyond adding new facilities. Alongside continued investments in outpatient healthcare entities, the hospital operator agreed to acquire The College of Health Care Professions, a move that could help strengthen its future workforce. These efforts have expanded its footprint to 189 hospitals and approximately 2,600 ambulatory sites, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics.
The investment pipeline remains strong. HCA has approved $5.5-$6 billion in capital projects that are expected to add hospital beds and emergency room capacity over the next 24 to 30 months. While a milder respiratory season and January winter storms temporarily weighed on first-quarter volumes, patient trends improved through February and March, supporting the decision to reaffirm 2026 guidance.
The continued buildout of hospitals and outpatient facilities reflects HCA's long-term commitment to meeting rising healthcare demand. As these projects come online, they should improve patient access, support future patient volumes and strengthen its long-term growth outlook.
How Do Peers Compare?HCA is not alone in capitalizing on the shift toward outpatient care. Medical peers such as Tenet Healthcare Corporation (THC - Free Report) and Universal Health Services, Inc. (UHS - Free Report) are also expanding their outpatient and hospital networks to meet growing demand for cost-effective, high-quality care.
Tenet Healthcare continues to expand its outpatient footprint through its USPI business while selectively investing in hospital operations. Tenet Healthcare's strategy focuses on increasing ambulatory surgery center capacity, supporting long-term revenue and earnings growth.
Universal Health is expanding its healthcare network through hospital projects, behavioral health facilities and selective acquisitions. Universal Health continues to add capacity to meet rising demand, supporting its long-term growth strategy.
HCA’s Price Performance, Valuation & EstimatesShares of HCA Healthcare have gained 10.4% over the past year compared with the industry's 13.1% growth over the same period.
Image Source: Zacks Investment Research
From a valuation standpoint, HCA trades at a forward price-to-earnings ratio of 13.21X, down from the industry average of 16.57X. HCA carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for HCA’s 2026 earnings is pegged at $30.07 per share, implying a 6.6% jump from the year-ago period’s level.
Image Source: Zacks Investment Research
HCA currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Dycom zvýšil výhled pro fiskální rok 2027 po rekordním backlogu 11,9 miliardy USD a silné poptávce po AI a digitální infrastruktuře. Tržby za 2. čtvrtletí odhaduje na 1,94–2,01 miliardy USD.
Key Takeaways Dycom raised fiscal 2027 guidance after a record backlog and strong demand for AI and digital infrastructure.DY expanded margins through disciplined execution, favorable project mix and growth in Building Systems.Dycom is boosting long-term growth through acquisitions, workforce investment and digital infrastructure. Dycom Industries, Inc. (DY - Free Report) is currently trading below the Zacks Building Products - Heavy Construction industry, with a forward 12-month price-to-earnings (P/E) ratio of 24.08, but above the broader Zacks Construction sector. The industry’s average currently is 25.48, while the sector’s valuation is 21.59.
Image Source: Zacks Investment Research
Despite trading at a discounted valuation relative to its long-term growth prospects, Dycom is benefiting from powerful secular trends, including accelerating AI-driven data center construction, cloud infrastructure expansion, fiber-to-the-home deployments, wireless network upgrades and government-funded broadband programs.
These demand drivers have fueled a record backlog and prompted management to raise its fiscal 2027 outlook, providing strong multi-year revenue visibility. Supported by expanding margins, strategic acquisitions and growing exposure to high-value digital infrastructure projects, the company's current valuation appears attractive for investors seeking long-term growth.
Shares of this specialty contracting firm, operating in the telecom industry, have gained 13.1% in the past three months, outperforming the industry, the sector and the S&P 500 Index. Notably, during the same time frame, DY has outrun a few of the notable peers, including MasTec, Inc. (MTZ - Free Report) , EMCOR Group, Inc. (EME - Free Report) and Jacobs Solutions, Inc. (J - Free Report) . The price performances can be observed in detail in the chart given below, wherein MasTec is seen with a gain of 9.3%, while EMCOR and Jacobs tumbled 0.2% and 1.6%, respectively.
Image Source: Zacks Investment Research
Let’s decode the factors backing Dycom stock’s growth prospects in the upcoming period.
AI-Driven Digital Infrastructure Demand TrendsDycom is benefiting from unprecedented investment in AI-driven digital infrastructure, creating a favorable long-term demand environment. Explosive growth in cloud computing, Artificial Intelligence workloads and hyperscale data centers is driving the need for fiber infrastructure, inside-the-fence connectivity, electrical systems and long-haul network deployments. At the same time, fiber-to-the-home expansion, wireless network modernization and government broadband initiatives continue to provide multiple growth avenues.
These favorable trends translated into a record first-quarter fiscal 2027 backlog of $11.9 billion, up 46.5% year over year, with a robust 2.2x book-to-bill ratio, providing strong revenue visibility. Customers are also extending contract durations to secure DY’s skilled workforce for multi-year projects, strengthening backlog quality and positioning it to capitalize on sustained digital infrastructure spending for years ahead. These market tailwinds not only support Dycom but also its close peers, including MasTec, EMCOR and Jacobs.
Margin Expansion & Improving Profitability OutlookDycom continues to demonstrate meaningful profitability improvement through disciplined execution, operating leverage and a favorable project mix. First-quarter fiscal 2027 adjusted EBITDA margin expanded 141 basis points (bps) year over year to 13.4%, while the Communications segment delivered a 31-bps margin expansion despite continued investments in workforce expansion and geographic growth. Meanwhile, the Building Systems segment significantly outperformed expectations, generating an impressive 17.7% adjusted EBITDA margin as Power Solutions ramped faster than anticipated.
Management expects profitability to improve further throughout fiscal 2027, with modest margin expansion in Communications driven by operating leverage and sustained high-teen margins in Building Systems. Continued scaling of data center projects, productivity improvements, disciplined project selection, successful integration of acquisitions and expanding higher-value digital infrastructure work are expected to support ongoing earnings growth.
Raised Fiscal 2027 Outlook Signals Sustained GrowthFollowing a record first quarter of fiscal 2027 that exceeded expectations, Dycom raised its fiscal 2027 outlook, reflecting confidence in both execution and end-market demand. The company now expects total contract revenues between $7.38 billion and $7.65 billion (from $6.85-$7.15 billion), driven by continued strength across Communications and Building Systems segments. Communications segment’s revenues are projected at $6.03-$6.20 billion, while the Building Systems segment is expected to contribute $1.35-$1.45 billion, excluding the pending National Technology Integrators acquisition.
For the second quarter of fiscal 2027, management forecasts revenues of $1.94-$2.01 billion (up from $1.378 billion reported a year ago), adjusted EBITDA of $284-$303 million (up from $205.5 million reported a year ago) and adjusted EPS of $4.40-$4.82 (up from $3.33 reported a year ago). Strong customer commitments, expanding fiber deployments, accelerating data center activity and improving margins support management's increasingly optimistic growth expectations.
Disciplined Capital AllocationDycom's balanced capital allocation strategy combines organic investments, strategic acquisitions and shareholder returns to strengthen its competitive position. The company continues investing in workforce development, fleet expansion, technology and operational capabilities while pursuing acquisitions that enhance technical expertise and broaden customer relationships.
The successful acquisition of Power Solutions has expanded Dycom's exposure to the rapidly growing data center electrical contracting market, while the pending acquisition of National Technology Integrators further extends its capabilities into structured cabling, security systems and end-to-end digital infrastructure. These acquisitions create meaningful cross-selling opportunities across communications and building systems, enhancing long-term growth potential. Supported by healthy liquidity, manageable leverage and record backlog, DY remains well-positioned to pursue additional accretive acquisitions while capitalizing on accelerating AI, cloud and broadband infrastructure investments.
Earnings Estimate Trend Favors DycomDycom’s earnings estimates for fiscal 2027 and fiscal 2028 have trended upward over the past 30 days to $16.35 per share and $19.95 per share, respectively. The estimated figures for fiscal 2027 and fiscal 2028 imply year-over-year growth of 36.6% and 22%, respectively.
Image Source: Zacks Investment Research
DY’s ROE PositionDycom’s superior return on equity (ROE) indicates its growth potential. It provides solid investment returns relative to the industry average, as reflected in its current trailing 12-month ROE of 24.13%. This compares favorably with the industry's ROE of 22.65%. The factor mentioned above indicates the company’s efficiency in using its shareholders’ funds, along with its ability to generate profit with minimum capital usage.
Image Source: Zacks Investment Research
Should You Invest in DY Stock Now?Dycom stock continues to trade below the industry’s valuation while benefiting from powerful secular growth drivers, including AI-driven data center expansion, fiber-to-the-home deployments, cloud infrastructure investments and government-backed broadband programs. Record backlog, strategic acquisitions and raised fiscal 2027 guidance provide strong revenue visibility, while margin expansion and disciplined execution are expected to drive sustained earnings growth.
Moreover, upward revisions to fiscal 2027 and 2028 earnings estimates, coupled with an industry-leading return on equity, reinforce confidence in the company’s growth trajectory. Although macroeconomic uncertainty and execution risks remain, Dycom’s discounted valuation relative to its long-term prospects offers an attractive risk-reward profile.
Thus, backed by a Zacks Rank #1 (Strong Buy) currently, DY stock remains a compelling buy at current levels rather than waiting for a better entry point. You can see the complete list of today’s Zacks #1 Rank stocks here.
Akcie Ingevity letos vzrostly o 24,8 % a překonaly 18,1% růst odvětví díky prodeji aktiv, akvizicím a vyšší poptávce po hybridech. Prodej Ozark Road Markings přinesl zhruba 65 mil. USD.
Key Takeaways Ingevity shares have surged 24.8% YTD, outperforming the specialty chemicals industry's 18.1% gain.NGVT is streamlining via divestitures, acquisitions and cost cuts to improve margins and earnings quality.NGVT benefits from hybrid demand, boosting activated carbon sales and Performance Materials growth. Ingevity Corporation (NGVT - Free Report) shares have rallied 24.8% year to date. The company has also outperformed the Zacks Chemical - Specialty industry’s 18.1% growth over the same time frame. The rally has been driven by Ingevity's successful portfolio optimization strategy, improving demand for higher-value hybrid vehicle applications and pricing actions that have strengthened earnings growth and reinforced confidence in the company’s long-term growth outlook.
Image Source: Zacks Investment Research
Let’s take a look at the factors that are driving NGVT stock.
Portfolio Optimization & Hybrid Vehicle Demand Drive GrowthIngevity is benefiting from its ongoing portfolio optimization and simplification strategy, which is aimed at sharpening its focus on higher-margin businesses and improving overall earnings quality. The company has made significant progress by divesting its Industrial Specialties business, Ozark Materials Road Markings product line and crude tall oil refinery, while continuing the divestiture process for its Advanced Polymer Technologies business. The company has recently completed the sale of its Ozark Road Markings business for approximately $65 million as part of these initiatives.
Additionally, value-creating acquisitions such as Georgia-Pacific’s pine chemicals business have driven earnings and revenue growth. The company has also undertaken actions to lower costs and boost profitability. The ability of NGVT to offset inflation through pricing power also enabled solid financial results despite an uncertain macroeconomic environment.
Alongside the portfolio transformation actions, Ingevity is benefiting from the adoption of hybrid vehicles. Following the expiration of EV tax credits, consumer preference has shifted toward hybrids, which has increased the long-term role of advanced and higher-value activated carbon solutions. This favorable product mix, combined with pricing actions, drove higher sales and stronger margins in Ingevity’s strongest segment, Performance Materials. Management also expects the transition toward hybrids to become a broader global trend, creating a long-term growth opportunity for its high-margin Performance Materials business.
Together, the company's strategic portfolio optimization and increasing exposure to higher-value hybrid vehicle applications position it for stronger earnings growth, improved profitability and sustainable shareholder value creation.
NGVT’s Zacks Rank & Other Key PicksNGVT currently carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks in the Basic Materials space are Albemarle Corporation (ALB - Free Report) , Carpenter Technology Corporation (CRS - Free Report) and Avino Silver & Gold Mines Ltd. (ASM - Free Report) .
While ALB sports a Zacks Rank #1 (Strong Buy) at present, CRS and ASM carry a Zacks Rank #2 each. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for ALB’s 2026 earnings is pinned at $12.98 per share, indicating a 1,743.04% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed one, with an average surprise of 74.5%. ALB’s shares have jumped 90.5% over the past year.
The Zacks Consensus Estimate for CRS’ 2026 earnings is pegged at $10.56 per share, indicating a rise of 41.18% year over year. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 8.95%.
The Zacks Consensus Estimate for ASM’s current fiscal-year earnings is pinned at 34 cents per share, indicating a 17.24% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 125%. ASM’sshares have gained 86.4% over the past year.
Lamb Weston ve 3. čtvrtletí fiskálního roku 2026 zvýšil objem v Severní Americe o 12 % a čisté tržby o 5 %. Cílové úspory nákladů pro fiskální rok 2026 splnil už před koncem čtvrtletí.
Key Takeaways Lamb Weston's "Focus to Win" strategy is delivering gains in North America volumes and sales.Lamb Weston posted 12% North America volume growth and 5% net sales growth in fiscal Q3.Lamb Weston hit its fiscal 2026 cost-savings target by Q3 and is reinvesting selectively. Lamb Weston Holdings, Inc.’s (LW - Free Report) “Focus to Win” strategy is beginning to show tangible results, particularly in North America, suggesting its turnaround efforts are gaining traction. Introduced last year, the strategy marked a shift away from prioritizing scale toward focusing on markets, customers and investments that offer stronger long-term returns. The latest quarter indicates that this approach is starting to deliver measurable operational benefits.
The strongest evidence comes from customer execution. Lamb Weston reported a 12% increase in North America volumes and a 5% rise in net sales in the third quarter of fiscal 2026, driven by higher customer retention, new contract wins and market share gains. These gains came despite only a modest 1% increase in U.S. quick-service restaurant traffic, underscoring the company's ability to outperform the broader market. Management attributed the improvement to stronger customer relationships, a revamped direct sales organization and better operational consistency.
Operational discipline is also paying off. Lamb Weston had targeted $100 million in cost savings for fiscal 2026 as part of its broader plan to deliver at least $250 million in savings by fiscal 2028. Notably, the company achieved the full-year savings target by the end of the fiscal third quarter, putting the program ahead of schedule. Instead of simply cutting costs, management has selectively reinvested part of these savings into customer support, product innovation and service quality to strengthen its competitive position.
The strategy also extends to capital allocation. Lamb Weston has become more selective with investments, closing inefficient facilities, reducing capital spending and prioritizing projects with stronger returns. While international operations remain under pressure, management emphasized that these structural actions are intended to create a leaner, more agile organization.
Although the transformation is still underway, the latest results suggest that “Focus to Win” is moving beyond a strategic blueprint and translating into improved customer momentum, stronger execution and a more disciplined operating model.
Lamb Weston’s Zacks Rank & Share Price PerformanceShares of this Zacks Rank #3 (Hold) company have gained 8.3% in the past month compared with the broader Consumer Staples sector, the industry and the S&P 500 index’s 4.9%, 7.7% and 0.7% growth, respectively.
LW Stock's Past Month Performance
Image Source: Zacks Investment Research
Is LW a Value Play Stock?Lamb Weston currently trades at a forward 12-month P/E ratio of 14.67, which is slightly down from the industry average of 14.77. This valuation positions the stock at a modest discount relative to its direct peers.
LW P/E Ratio (Forward 12 Months)
Image Source: Zacks Investment Research
Stocks to ConsiderUnited Natural Foods, Inc. (UNFI - Free Report) distributes natural, organic, specialty, produce and conventional grocery and non-food products in the United States and Canada. At present, United Natural sports a Zacks Rank of 1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The consensus estimate for United Natural’s current fiscal-year earnings implies growth of 254.9% from the year-ago figures. UNFI delivered a trailing four-quarter earnings surprise of 29.9%, on average.
Mama's Creations, Inc. (MAMA - Free Report) manufactures and markets fresh deli-prepared foods in the United States. At present, MAMA holds a Zacks Rank of 2 (Buy). Mama's Creations delivered a trailing four-quarter earnings surprise of 129.2%, on average.
The consensus estimate for Mama's Creations’ current fiscal-year sales and earnings implies growth of 30% and 73.3%, respectively, from the year-ago figures.
Hormel Foods Corporation (HRL - Free Report) develops, processes and distributes various meat, nuts and other food products to foodservice, convenience store and commercial customers in the United States and internationally. It carries a Zacks Rank of 2 at present. HRL delivered a trailing four-quarter earnings surprise of 3.2%, on average.
The Zacks Consensus Estimate for Hormel Foods’ current fiscal-year sales and earnings indicates growth of 1.5% and 9.5%, respectively, from the prior-year reported levels.
Wendy’s v USA zvýšila digitální tržby o 8,4 % a digitál tvořil 22,7 % domácích tržeb. Zároveň ale tržby ve stejných provozovnách v USA klesly o 7,8 % kvůli slabší návštěvnosti.
Key Takeaways Wendy's grew U.S. digital sales 8.4%, with digital channels accounting for 22.7% of domestic sales.WEN is enhancing customer engagement through AI-powered recommendations and value-focused menu offerings.Digital initiatives, operational improvements and Project Fresh aim to support Wendy's sales recovery. The Wendy's Company (WEN - Free Report) is betting that its expanding digital ecosystem can help revive sales as it works through a challenging traffic environment. While first-quarter 2026 results reflected continued pressure on customer visits, management believes its digital investments and operational improvements can support a gradual turnaround.
The company reported a 7.8% decline in U.S. same-restaurant sales, primarily due to weaker traffic, adverse weather and adjustments to restaurant operating hours. However, digital remained a bright spot. U.S. digital sales climbed 8.4% year over year, with digital channels accounting for 22.7% of domestic sales. Wendy’s also integrated an AI-powered recommendation engine into its mobile app to personalize orders based on cart contents, restaurant location and seasonal preferences, while adding more payment options to improve checkout conversion.
Beyond technology, Wendy’s is strengthening its "Project Fresh" turnaround strategy by upgrading menu quality, improving restaurant operations and refining marketing efforts. The company introduced enhanced hamburgers and revamped spicy chicken sandwiches, expanded value offerings through its Biggie Deals platform and is leveraging targeted promotions to increase customer engagement. Management noted that restaurants with higher customer satisfaction scores significantly outperform weaker locations, underscoring the importance of operational execution.
Still, digital growth alone may not fully offset declining store traffic in the near term. Inflationary pressures, cautious lower-income consumers and intense competition continue to weigh on demand. Nevertheless, Wendy’s maintained its full-year outlook, expecting sales trends to improve progressively as digital initiatives, menu innovation and operational enhancements gain traction. If these efforts translate into higher customer frequency, digital momentum could become a meaningful driver of Wendy’s broader turnaround story.
MCD and QSR International Raise the Competitive BarWendy's digital ambitions face stiff competition from larger quick-service restaurant players that have already built strong digital ecosystems. McDonald's (MCD - Free Report) continues to leverage its global loyalty program, mobile app, delivery partnerships and AI-driven personalization to boost customer engagement and repeat visits. Its extensive digital infrastructure and value offerings help drive traffic even in a challenging consumer environment, making McDonald's a formidable rival.
Restaurant Brands International's (QSR - Free Report) Burger King is also accelerating the digital transformation through its Royal Perks loyalty program, mobile ordering and targeted promotions. Under its "Reclaim the Flame" strategy, Burger King is investing in restaurant modernization, technology upgrades and value-focused marketing to improve guest traffic and franchise performance.
For Wendy's, growing digital sales is encouraging, but sustaining momentum will require converting online engagement into higher restaurant traffic. Continued investments in AI-powered recommendations, loyalty initiatives, menu innovation and operational improvements will be essential to narrowing the competitive gap with McDonald's and Burger King while strengthening its long-term market position.
WEN’s Price Performance, Valuation & EstimatesShares of Wendy’s have gained 11.9% in the past three months against the industry’s 0.4% decline.
WEN Three-Month Price Performance
Image Source: Zacks Investment Research
From a valuation standpoint, WEN trades at a forward price-to-sales (P/S) multiple of 0.67, below the industry’s average of 3.41.
WEN’s P/S Ratio (Forward 12-Month) vs. Industry
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for WEN’s 2026 earnings per share (EPS) implies a year-over-year decline of 34.1%. The EPS estimates for 2026 have remained unchanged in the past 30 days.
EPS Trend of WEN Stock
Image Source: Zacks Investment Research
WEN’s Zacks RankWEN stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Dolce Vita ve Steven Madden zaznamenala silnou jarní sezónu díky poptávce po jelly, raffia a woven stylech a vedení očekává v roce 2026 vysoký jednociferný růst tržeb.
Key Takeaways Steven Madden's Dolce Vita delivered a strong spring season with healthy wholesale sell-through.Steven Madden is growing Dolce Vita's handbag business and expanding its global footprint.Steven Madden projects high single-digit 2026 revenue growth for Dolce Vita amid strong demand. Dolce Vita is gaining momentum within Steven Madden, Ltd. ’s (SHOO - Free Report) brand portfolio as strong consumer demand and trend-driven products continue to fuel performance. During the spring season, the brand benefited from healthy demand for jelly, raffia and woven styles across footwear and handbags, leading to robust sell-through at major wholesale partners such as Nordstrom, Dillard’s and Macy’s.
Beyond seasonal product strength, Dolce Vita is pursuing initiatives aimed at expanding its long-term addressable market. Management is focused on growing the handbag business and increasing the brand’s international presence, moves that should provide additional revenue opportunities and support a more diversified business model over time.
The brand’s wholesale performance has been particularly encouraging. Management noted that Dolce Vita recorded a very strong spring season and was outperforming the Steven Madden label in sell-through at its largest retail customer. This suggests increasing consumer affinity for the brand and reinforces its ability to gain shelf space and capture incremental demand within key distribution channels.
Dolce Vita’s momentum coincides with improving fundamentals at the parent company. Steven Madden reported first-quarter 2026 revenues of $653.1 million, up 18% year over year, prompting management to raise its fiscal 2026 sales outlook to growth of 10-12% from the prior expectation of 9-11%. Notably, the company increased expectations for each of its three largest brands — Steven Madden, Kurt Geiger and Dolce Vita — highlighting broad-based strength across the portfolio.
Management continues to project high single-digit revenue growth for Dolce Vita in 2026. Supported by favorable demand trends, category expansion initiatives and growing international exposure, the brand appears increasingly well positioned to become a more meaningful contributor to Steven Madden’s long-term growth story.
SHOO’s Price Performance, Valuation & EstimatesShares of the company have risen 58.6% over the past year against the industry’s 33.4% decline.
Image Source: Zacks Investment Research
From a valuation standpoint, Steven Madden is trading at a trailing 12-month price-to-sales ratio of 1.08X, down from the industry average of 1.34X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Steven Madden’s 2026 earnings implies year-over-year growth of 22.9%, whereas the same for 2027 indicates an uptick of 33.8%. Estimates for 2026 have been unchanged, while those for 2027 have been revised upward by 35 cents over the past 60 days.
Image Source: Zacks Investment Research
SHOO’s Zacks Rank & Other Key PicksSteven Madden currently sports a Zacks Rank #1 (Strong Buy).
Some other top-ranked stocks are Tapestry, Inc. (TPR - Free Report) , Genesco Inc. (GCO - Free Report) and Designer Brands Inc. (DBI - Free Report) .
Tapestry is the designer and marketer of fine accessories and gifts for women and men in the United States and internationally. The company sports a Zacks Rank #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Tapestry’s current fiscal-year earnings and sales indicates growth of 36.3% and 13.8%, respectively, from the year-ago actuals. TPR delivered a trailing four-quarter average earnings surprise of 15.6%.
Genesco is a Nashville-based specialty retail and branded company. It sells footwear and accessories in retail stores. The company also flaunts a Zacks Rank #1 at present.
The Zacks Consensus Estimate for Genesco’s current fiscal-year earnings indicates growth of 55.2% from the year-ago actuals. GCO delivered a trailing four-quarter average earnings surprise of 3.8%.
Designer Brands designs, produces and retails footwear and accessories. It offers shoes, boots, sandals, sneakers, socks, handbags and accessories. It currently carries a Zacks Rank #2 (Buy).
The Zacks Consensus Estimate for Designer Brands’ current fiscal-year earnings and sales suggests growth of 137.5% and 0.5%, respectively, from the year-ago actuals. DBI delivered a trailing four-quarter average earnings surprise of 112.8%.
Quanta Services zvýšila výhled na rok 2026 po rekordních tržbách za 1. čtvrtletí a backlogu 48,5 miliardy USD. Akcie za rok vzrostly o 78,6 % a obchodují se na 44,11násobku očekávaných zisků.
Key Takeaways Quanta has surged 78.6% in a year, outpacing its industry, sector and the S&P 500.PWR trades at 44.11X forward earnings, well above the industry average of 29.8X.Quanta raised 2026 guidance after record Q1 revenue and backlog reached $48.5 billion. Quanta Services (PWR - Free Report) has been one of the biggest winners in the infrastructure sector over the past year, with its stock soaring 78.6%. The rally has comfortably outpaced the Zacks Engineering - R&D Services industry's 36.8% gain, the Zacks Construction sector's 18.9% advance and the S&P 500's 23.9% rise. Investors have rewarded the company for consistently delivering strong earnings, expanding its backlog and positioning itself at the center of several long-term infrastructure trends.
PWR Price Performance (1 Year)
Image Source: Zacks Investment Research
PWR's Technical Trend
Image Source: Zacks Investment Research
The stock's impressive performance, however, has come with a higher price tag. Quanta now trades at a forward 12-month price-to-earnings (P/E) multiple of 44.11X, significantly above the industry average of 29.8X. While Wall Street remains optimistic about the company's long-term prospects, investors now face an important question: Does Quanta's business outlook justify paying such a premium, or has much of its future growth already been priced into the stock?
PWR Valuation (P/E F12M) vs Industry
Image Source: Zacks Investment Research
The answer depends on whether Quanta can continue converting its industry-leading project pipeline into sustained earnings growth while maintaining strong execution. Let's take a closer look at what continues to support the investment case and the factors that could limit further upside.
Quanta's Growth Drivers Remain StrongQuanta continues to benefit from one of the most attractive infrastructure spending environments in decades. Rising electricity demand, AI-driven data center construction, renewable energy integration, transmission expansion and electric grid modernization are creating significant opportunities across its end markets.
The company has evolved beyond being a traditional contractor into a provider of integrated infrastructure solutions. Its engineering expertise, skilled workforce, fabrication capabilities and supply-chain investments allow it to execute increasingly complex projects for utilities, hyperscalers and industrial customers. This integrated approach has strengthened customer relationships and enabled Quanta to participate earlier in customers' multiyear capital planning cycles.
Management also continues investing to support future demand. The company is expanding transformer manufacturing capacity and nearly doubling its off-site fabrication and logistics footprint, positioning itself to capitalize on accelerating investments in power infrastructure and AI-related projects. These investments should strengthen Quanta's competitive advantage as customers increasingly prioritize execution certainty and supply-chain reliability.
Strong Execution Supports Higher Earnings Outlook for PWRQuanta's first-quarter 2026 results reinforced confidence in its long-term growth strategy. Revenues increased 26.3% year over year to a record $7.87 billion, while adjusted earnings per share (EPS) climbed to $2.68 from $1.78 in the prior-year quarter. Both the Electric Infrastructure Solutions and Underground & Infrastructure Solutions segments delivered margin expansion, highlighting disciplined project execution and favorable work mix. The company also ended the quarter with a record total backlog of $48.5 billion, providing excellent revenue visibility over the coming years.
Following the strong start to the year, management raised its full-year 2026 outlook. Quanta now expects revenues between $34.7 billion and $35.2 billion and adjusted EPS between $13.55 and $14.25, reflecting improved visibility across its utility, power generation and large-load infrastructure businesses.
Management remains equally optimistic about the longer term. At its recent Investor Day, Quanta outlined a strategy to more than double adjusted earnings power by 2030, supported by an estimated $2.4 trillion addressable market spanning utilities, power generation and large-load infrastructure.
Analysts also remain constructive. Over the past 60 days, the Zacks Consensus Estimate for 2026 EPS has increased from $13.87 to $14.03, representing expected growth of 30.5% from 2025. Revenue estimates point to 22.1% growth in 2026, followed by continued double-digit growth in 2027.
PWR EPS Estimate
Image Source: Zacks Investment Research
PWR Stock’s Premium Valuation Demands Continued ExecutionQuanta's biggest challenge today is not demand but valuation. Despite trading below its 50-day moving average, the stock still commands a forward P/E multiple of 44.11X, substantially above the industry average of 29.8X. Such a premium reflects investor confidence that Quanta can sustain above-average earnings growth for several years.
Wall Street's optimism remains evident. The stock carries an Average Brokerage Recommendation (ABR) of 1.37, with 22 of the 27 analysts rating it a Strong Buy. Analysts' average price target of $808.00 also implies roughly 20% upside from current levels.
Image Source: Zacks Investment Research
Nevertheless, premium valuations leave little room for disappointment. Any slowdown in backlog growth, project execution or margin expansion could pressure the stock more than lower-valued peers.
Macro Risks Could Create Near-Term VolatilityAlthough Quanta's long-term outlook remains favorable, several external factors could influence future performance.
Large infrastructure projects are often subject to permitting delays, regulatory approvals, adverse weather, supply-chain disruptions and changing customer schedules. Inflation, tariffs, labor shortages and higher interest rates may also increase project costs or delay customer capital spending.
Management acknowledged that weather, permitting, regulatory issues, trade policy, supply-chain conditions and broader macroeconomic uncertainty remain important variables affecting project timing and financial performance, even as underlying demand remains robust.
How Quanta Stacks Up Against CompetitorsQuanta competes with EMCOR Group (EME - Free Report) , Sterling Infrastructure (STRL - Free Report) and Comfort Systems USA (FIX - Free Report) across several infrastructure and mission-critical construction markets.
From a share price perspective, Comfort Systems has delivered the strongest performance, with shares rising roughly 240% over the past year. Sterling Infrastructure follows closely with a gain of 215.9%, while Quanta has advanced 78.6%. Although Quanta has significantly outperformed EMCOR, whose shares have gained 45.5%, it has lagged the exceptional rallies posted by Comfort Systems and Sterling Infrastructure.
Valuation paints a different picture. EMCOR trades at the lowest forward P/E multiple of 25.27X, suggesting a more modest growth premium. Sterling Infrastructure trades at 31.76X, while Comfort Systems commands 37.37X. Quanta's forward P/E of 44.11X is the highest among the four companies, indicating that investors assign the greatest premium to Quanta's earnings visibility, diversified business model and long-term infrastructure opportunities.
Should Investors Buy PWR Stock Now?Quanta continues to execute at a high level. Record backlog, improving financial guidance, rising earnings estimates and strong demand across electric infrastructure, AI data centers and power generation provide a solid foundation for long-term growth. Management's investments in manufacturing capacity, supply-chain capabilities and integrated solutions further strengthen its competitive position for the coming decade.
However, the stock's premium valuation cannot be ignored. After nearly an 80% gain over the past year, investors are paying a substantial premium for Quanta's quality and growth prospects. While the business fundamentals continue to justify optimism, the current valuation reduces the margin of safety and makes flawless execution increasingly important.
Considering the company's attractive long-term outlook alongside its elevated valuation, the current Zacks Rank #3 (Hold) appears appropriate. Existing investors can remain confident in Quanta's multiyear growth story, while new investors may benefit from waiting for either a more attractive entry point or further earnings growth to better support the premium multiple. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
MarketAxess ve 2. čtvrtletí zobchodoval kreditní objem přes 1,04 bilionu USD, i když celkový ADV meziročně klesl o 11 % na 43,6 miliardy USD. Podíl na trhu u amerického kreditního portfolio tradingu stoupl na 20,6 %.
Key Takeaways MKTX handled more than $1.04T in Q2 credit trading volume, even as total ADV declined 11% year over year.MKTX saw growth in Emerging Markets, portfolio trading and record Mid-X volume offset weaker U.S. rates.MarketAxess' U.S. credit portfolio trading market share rose to 20.6% as Q2 EPS is projected to decline. MarketAxess Holdings Inc. (MKTX - Free Report) recently announced that in the second quarter of 2026, it recorded a total trading average daily volume (ADV) of $43.6 billion, an 11% year-over-year decrease. Nevertheless, its electronic trading platform facilitated more than $1.04 trillion in total credit trading volume in the quarter, increasing 1% year over year.
Growth in Emerging markets (+12%) and Agencies and Other Government Bond Rates (+84%) supported the total volume, offset by declines in U.S. Government Bond Rates (-22%), High-grade (-4%) and High-yield (-8%). Eurobonds markets saw a 1% increase in ADV from the year-ago period.
Total credit average variable transaction fees per million (“FPM”) declined 7% year over year in the quarter due to product and protocol mix and lower duration in U.S. high-grade, while the same for total rates jumped 24% year over year due to protocol mix. The number of trading days in the United States and the U.K. were 62 and 61, respectively, in the second quarter. Its estimated market share of U.S. credit portfolio trading came at 20.6%, rising from 17.5% a year ago.
The second quarter figures indicate 33% rise in total portfolio trading ADV to $2 billion, but Dealer-initiated ADV of $1.7 billion fell 3% year over year. It also announced that total Mid-X trading volume surged 156% to a record $23.6 billion.
Where Do Q2 Estimates Stand?The Zacks Consensus Estimate for MarketAxess’ second-quarter earnings is pegged at $1.90 per share, which indicates a 5% year-over-year decrease. The consensus mark for revenues stands at $220.43 million, suggesting a 0.4% year-over-year increase. Notably, the company has surpassed earnings estimates in each of the past four quarters, with an average surprise of 4.5%.
Zacks Rank & Key PicksMarketAxess currently has a Zacks Rank #4 (Sell).
Some better-ranked stocks in the broader Finance space are Cboe Global Markets, Inc. (CBOE - Free Report) , Nasdaq, Inc. (NDAQ - Free Report) and Chime Financial, Inc. (CHYM - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for Cboe Global’s current-year earnings is pegged at $13.36 per share, signaling 25.2% year-over-year increase. CBOE beat earnings estimates in each of the past four quarters, with an average surprise of 5.4%. The consensus mark for its current-year revenues is pegged at $2.75 billion, a 13.1% jump from a year ago.
The Zacks Consensus Estimate for Nasdaq’s 2026 earnings indicates 11.2% year-over-year growth. During the past month, NDAQ has witnessed one upward estimate revision against none in the opposite direction. It beat earnings estimates in each of the past four quarters, with an average surprise of 4.9%.
The Zacks Consensus Estimate for Chime Financial’s current-year earnings suggests a 107% year-over-year improvement. During the past 60 days, CHYM has witnessed two upward estimate revisions against none in the opposite direction. The consensus mark for current-year revenues suggests a 22.6% jump from a year ago.
Key Takeaways Dutch Bros saw rewards members make up 74% of all transactions in Q1 2026.Dutch Bros' system same-shop transactions rose 5.1%, marking a seventh straight quarter of growth.Dutch Bros plans at least 185 new shops in 2026 and projects revenues of $2.05B-$2.08B. Dutch Bros Inc. (BROS - Free Report) has steadily transformed its digital rewards platform into one of its strongest competitive advantages. During the first quarter of 2026, 74% of all transactions were made by Dutch Rewards members, highlighting how deeply the loyalty program has become embedded in customer behavior. Rather than simply rewarding repeat visits, the platform is increasingly serving as a growth engine that drives frequency, supports new product launches, enhances marketing efficiency and encourages higher customer engagement.
A loyalty program is most valuable when it increases customer visits rather than merely rewarding existing purchases. Dutch Bros appears to be achieving that objective. During the first quarter, system same-shop transactions increased 5.1%, marking the company's seventh consecutive quarter of transaction growth. System same-shop sales rose 8.3%, while company-operated same-shop sales increased 10.6%. Unlike many restaurant companies that continue relying heavily on pricing, Dutch Bros generated healthy transaction growth alongside moderate ticket expansion, indicating that more customers are visiting its shops rather than simply paying higher prices.
Management credited the momentum to stronger customer engagement and rising Dutch Rewards adoption. The app gives Dutch Bros better visibility into purchase frequency, favorite beverages, seasonal demand and regional trends. These insights help the company personalize offers, target limited-time beverages to the right customers and support food promotions more effectively. Higher digital engagement also creates opportunities to launch new beverages more efficiently, promote food offerings and communicate seasonal campaigns without significantly increasing marketing expenses. As the rewards ecosystem expands, customer acquisition costs could decline while repeat visitation continues improving.
The loyalty platform becomes even more valuable as Dutch Bros continues opening new locations. The company finished the first quarter with 1,177 shops after opening 41 new stores during the quarter and now expects to open at least 185 new shops during 2026. Management also raised its full-year outlook, projecting revenues between $2.05 billion and $2.08 billion and same-shop sales growth of approximately 4-6%.
Dutch Bros' 74% rewards penetration represents far more than a loyalty statistic. It reflects an increasingly data-driven customer ecosystem that supports repeat visits, personalized marketing and more efficient expansion into new markets. The company's recent transaction growth suggests the strategy is already delivering tangible benefits. If Dutch Bros continues combining strong rewards engagement with disciplined new-store expansion, menu innovation and effective digital marketing, its loyalty platform could remain an important catalyst for sustaining faster traffic growth over the coming years.
Rewards Programs Become a Key Competitive BattlegroundDutch Bros' success in driving 74% of transactions through its Dutch Rewards program reflects a broader industry trend, with peers like Starbucks Corporation (SBUX - Free Report) and Shake Shack Inc. (SHAK - Free Report) increasingly investing in digital ecosystems to boost customer frequency, personalization and long-term loyalty.
Starbucks continues to strengthen its Rewards platform as part of its "Back to Starbucks" strategy. SBUX reported a record 35.6 million active U.S. Rewards members in the second quarter of fiscal 2026 and introduced new redemption options and personalized benefits to encourage more frequent visits. Management noted that the redesigned program is already increasing customer engagement and visit frequency, positioning Rewards as a key growth engine rather than simply a discount program.
Shake Shack is also expanding its digital engagement strategy. While the company has yet to launch its loyalty program, management plans to introduce it later in 2026 as part of its broader Project Catalyst initiative. The platform is designed to deepen guest engagement, improve retention and increase lifetime value through personalized experiences rather than points-based discounts, while SHAK’s growing digital customer base provides the data needed to support targeted marketing.
Against this backdrop, Dutch Bros appears well positioned with an already mature rewards ecosystem. With nearly three-fourths of transactions flowing through Dutch Rewards, the company has built a sizable base for personalized marketing, product launches and customer retention.
BROS’ Price Performance, Valuation & EstimatesShares of Dutch Bros have gained 22.7% in the past three months against the industry’s decline of 0.4%.
BROS Stock’s Three-Month Price Performance
Image Source: Zacks Investment Research
From a valuation standpoint, Dutch Bros stock trades at a forward price-to-sales ratio of 5.13, above the industry’s average of 3.41.
BROS’ P/s Ratio (Forward 12-Month) vs. Industry
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for BROS’ 2026 earnings per share (EPS) implies a year-over-year uptick of 22.4%. EPS estimates for 2026 have increased in the past 30 days.
EPS Trend of BROS Stock
Image Source: Zacks Investment Research
Dutch Bros currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Kahn Swick & Foti, LLC zahájila vyšetřování společnosti Kyndryl Holdings kvůli možnému porušení povinností vedení vůči akcionářům. Firma zároveň uvedla, že nestihne včas podat formulář 10-Q za čtvrtletí končící 31. prosince 2025 a očekává významné slabiny v interních kontrolách za toto období, jakož i za celý fiskální rok končící 31. března 2025 a první dvě čtvrtletí fiskálního roku 2026.
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE: KD).
On February 9, 2026, the Company disclosed that it would be unable to timely file its Form 10-Q Report for the quarter ended December 31, 2025 and that “the Company anticipates reporting material weaknesses in the Company’s internal control over financial reporting for the period covered in the Quarterly Report, as well as for the full fiscal year ended March 31, 2025, and the first two fiscal quarters of fiscal year 2026, which are expected to include, but may not be limited to, the effectiveness and strength of certain functions at the Company, including with respect to controls related to information and communication and tone at the top,” as well as the departure of its C.F.O and General Counsel.
Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the class period in violation of federal securities laws, which remains ongoing.
KSF’s investigation is focusing on whether Kyndryl’s officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws.
If you have information that would assist KSF in its investigation, or have been a long-term holder of Kyndryl shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-833-938-0905 or email KSF Managing Partner Lewis Kahn ([email protected]), or visit https://ksfcounsel.com/cases/nyse-kd-2/ to learn more.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
AMN Healthcare letos posílila o 126,9 % a těží z růstu MSP, narušení pracovního trhu, poptávky i investic do AI. Rizikem zůstává slabost na klíčových staffing trzích a tlak na ceny.
Key Takeaways AMN Healthcare is poised for growth with its broad services, MSP momentum and demand from labor disruptions.AI tools in WorkWise and AMN Passport are boosting recruiting, engagement and workforce planning.Soft staffing markets, client concentration and regulatory challenges could pressure AMN's growth. AMN Healthcare Services, Inc. (AMN - Free Report) is well-poised for growth in the coming quarters, courtesy of its broad array of services. The optimism is led by strong momentum in its Managed Services Program (MSP), rising labor disruption demand and investments in technology and AI-driven platforms. However, industry shifts, pricing pressure and healthcare cost-consciousness are major downsides.
Shares of this Zacks Rank #3 (Hold) company have jumped 126.9% in the year-to-date period against the industry's 14.6% decline. However, the S&P 500 Index has risen 10.3% in the said timeframe.
This renowned player in the healthcare total talent services space has a market capitalization of $1.35 billion. The company projects 98.5% of earnings growth for 2026 and expects to witness continued improvements in its business. AMN Healthcare surpassed the Zacks Consensus Estimate in all the trailing four quarters, delivering an average earnings surprise of 53.25%.
Image Source: Zacks Investment Research
Factors Favoring AMN StockHealthcare Workforce Solutions Strengthening Client Relationships: AMN Healthcare is benefiting from a shift in healthcare providers' workforce priorities. During the first-quarter 2026 earnings call, management noted that hospitals are no longer primarily focused on reducing contract labor usage. They are seeking long-term workforce optimization through predictive analytics, technology-enabled staffing and total talent management. The company strengthened its MSP business by adding a new Locum MSP client, and renewing and expanding its largest Locums contract. These developments, combined with deeper client relationships built during recent labor disruption events, position AMN to capture additional market share as healthcare organizations increasingly prefer strategic workforce partners over traditional staffing vendors.
AI and Technology Investments Driving Operational Efficiency: AMN continues to leverage artificial intelligence and digital tools to improve recruiting efficiency, clinician engagement and workforce management. The company introduced new AI-powered capabilities within its WorkWise platform, including automated candidate scoring, enhanced job search functionality and AI-assisted job description creation. Its AI recruiter helped deploy more than 10,000 clinicians during the quarter, while the AMN Passport mobile app recorded more than 30% growth in users and over 50% growth in monthly active users.
The company recently partnered with Brightfield to enhance its workforce intelligence capabilities. Brightfield's Talent Data Exchange (TDX) complements AMN's proprietary workforce insights, improving market transparency and labor planning. The partnership also enhances AMN's WorkWise ecosystem with stronger decision-support capabilities.
These technology investments are improving hiring speed, strengthening clinician engagement and enhancing workforce planning capabilities, supporting management's long-term goal of expanding revenue while improving operating leverage.
Improving Core Business Momentum and Financial Strength: Beyond the temporary boost from labor disruption events, AMN Healthcare's underlying businesses showed encouraging signs of recovery. Excluding labor disruption assignments, Nurse and Allied Solutions returned to year-over-year traveler volume growth for the first time since 2022, while international staffing posted its first year-over-year revenue increase since late 2023. Leadership search also returned to growth, reflecting improving demand across multiple service lines. With improving demand trends, disciplined capital management and management targeting sustainable revenue growth alongside faster adjusted EBITDA expansion, the company appears well positioned for long-term growth.
Downsides of AMN StockSoftness in Key Staffing Markets: Although AMN's Nurse and Allied business is showing signs of recovery, some of its core staffing markets remain under pressure. During first-quarter 2026, management noted that physician staffing demand remains soft, with many Locums clients focusing on centralized program management and hiring permanent physicians. Demand has also shifted toward the more competitive third-party channel, where fill rates are lower and pricing pressure is higher. At the same time, healthcare systems are investing in internal recruiting capabilities, workforce analytics and AI-powered staffing tools, which could reduce reliance on external staffing providers over time.
Client Concentration and Industry Consolidation Risks: Consolidation among healthcare providers continues to strengthen customers' bargaining power, allowing them to negotiate lower staffing rates and centralize workforce management. Mergers may also result in the loss of contracts if the combined organizations choose existing vendors. AMN Healthcare derives approximately 22% of its consolidated revenues from Kaiser Foundation Hospitals, making the company dependent on a single large customer. As healthcare organizations use vendor management systems and group purchasing organizations, pricing pressure and customer concentration could weigh on future revenue growth and margins.
Regulatory and Competitive Challenges: AMN operates in a highly regulated and competitive healthcare staffing industry. Changes in Medicare and Medicaid reimbursement, workforce regulations, immigration policies and evolving rules surrounding AI, cybersecurity and data privacy could increase compliance costs and influence customer hiring decisions. The company also faces competition from large national staffing firms, specialized healthcare recruiters and technology-driven workforce providers. As hospitals continue expanding in-house staffing programs and adopting AI-enabled workforce management solutions, AMN Healthcare must invest in technology and service innovation to protect its competitive position.
Estimate TrendAMN Healthcare has been witnessing a positive estimate revision trend for 2026. Over the past 60 days, the Zacks Consensus Estimate for its earnings per share has improved 40% to $2.70.
The Zacks Consensus Estimate for second-quarter 2026 revenues and earnings per share is pegged at $626 million and 22 cents, respectively, suggesting 4.9% and 26.7% declines from the year-ago reported numbers.
Key PicksSome better-ranked stocks from the broader medical space are West Pharmaceutical (WST - Free Report) , Intuitive Surgical (ISRG - Free Report) and Pacific Biosciences of California (PACB - Free Report) .
West Pharmaceutical, carrying a Zacks Rank #2 (Buy) at present, reported first-quarter 2026 EPS of $2.13, which beat the Zacks Consensus Estimate by 26.8%. Revenues of $844.9 million surpassed the Zacks Consensus Estimate by 8.5%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
West Pharmaceutical has an estimated long-term earnings growth rate of 13.9%. WST’s earnings surpassed estimates in the trailing four quarters, the average surprise being 19.4%.
Intuitive Surgical, carrying a Zacks Rank #2 at present, reported first-quarter 2026 core earnings per share of 85 cents, which missed the Zacks Consensus Estimate by 20.2%. Revenues of $2.77 billion surpassed the Zacks Consensus Estimate by 6.2%.
Intuitive Surgical has a long-term estimated growth rate of 14.3%. ISRG’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 16.8%.
Pacific Biosciences of California, carrying a Zacks Rank #2 at present, reported a first-quarter 2026 adjusted loss per share of 12 cents, which came narrower than the Zacks Consensus Estimate by 29.4%. Revenues of $37.2 million missed the Zacks Consensus Estimate by 9.3%.
Pacific Biosciences of California has an estimated earnings growth rate of 22.6% for 2026. PACB’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 29.8%.
Howmet ve 1. čtvrtletí zvýšil tržby z obranného letectví o 10 % meziročně díky poptávce po dílech pro F-35 a starší stíhačky. Firma zároveň zvýšila výhled na rok 2026 na tržby 9,575–9,725 miliardy USD a EBITDA 3,025–3,095 miliardy USD.
Key Takeaways Howmet's defense aerospace revenues rose 10% in Q1, driven by F-35 engine spares and legacy fighter demand.HWM's Engine Products segment posted 29% revenue growth as defense aerospace strength continued.Howmet raised its 2026 outlook, expecting up to $9.725 billion in revenues and $3.095 billion in EBITDA. Howmet Aerospace Inc. (HWM - Free Report) is witnessing persistent strength in its defense aerospace market. In first-quarter 2026, revenues from the defense aerospace market surged 10% year over year, constituting 16% of the company’s revenues. Also, in 2025, revenues from this market increased 21% year over year. The surge in revenues was driven by the strong demand for engine spares, particularly related to the F-35 program, and increased orders for legacy fighter jet spares.
This uptick significantly benefited Howmet’s Engine Products segment, which reported a 29% year-over-year revenue increase in the first quarter. The company is expanding its efforts on new programs, particularly in the drone and collaborative combat aircraft space. With military-aircraft programs expected to benefit from increased funding, HWM is poised to maintain strong demand momentum in the upcoming quarters.
It's worth noting that the fiscal year 2026 Defense Appropriations Act was signed into law in February 2026, providing a strong budgetary allocation for defense. Such robust budgetary provisions set the stage for Howmet, which is focused on the defense business, to win more contracts, which is likely to boost its top line.
Driven by strength across both defense and commercial aerospace markets, the company raised its 2026 outlook and currently expects total revenues of $9.575-$9.725 billion and adjusted EBITDA of $3.025-$3.095 billion.
Segment Snapshot of HWM’s PeersTextron Inc.’s (TXT - Free Report) defense business is gaining momentum, backed by key U.S. military contracts and steady government support. In first-quarter 2026, Bell’s military revenues increased year over year, driven by continued growth on the MV-75 Cheyenne program. Textron Systems revenues increased 13% largely due to higher volume on the Ship-to-Shore Connector program and military training services at ATAC.
GE Aerospace (GE - Free Report) is benefiting from solid momentum in its Defense & Propulsion Technologies segment. In first-quarter 2026, GE Aerospace clinched a $1.4 billion deal for T408 engines to support the U.S. Marine Corps’ CH-53K helicopter fleet. Driven by strong bookings, revenues from the Defense & Propulsion Technologies segment increased 19% year over year and orders grew 67% in the first quarter.
HWM's Price Performance, Valuation and EstimatesShares of Howmet have surged 32.3% in the past six months against the industry’s decline of 1.7%.
Image Source: Zacks Investment Research
From a valuation standpoint, HWM is trading at a forward price-to-earnings ratio of 50.86X, above the industry’s average of 34.03X. Howmet carries a Value Score of D.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for HWM’s 2026 earnings has increased 9% over the past 60 days.
Image Source: Zacks Investment Research
The company currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
SoFi po jarním propadu za poslední měsíc vzrostla o 12,2 %, ale od začátku roku zůstává 31,3 % v minusu. Tržby za 1. čtvrtletí dosáhly 1,10 miliardy USD a překonaly odhady.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
SoFi Technologies (NASDAQ:SOFI | SOFI Price Prediction) is trading around $18 as of July 7, 2026, still down 31.3% year-to-date after a brutal spring. The catalyst for the drawdown: a March 2026 Muddy Waters report alleging accounting misstatements and undisclosed charge-off rates. Yet shares have rallied 12.2% over the past month, raising the question of whether the stock has bottomed.
The Fundamentals Never Broke The bear thesis was that credit was cracking beneath the surface. The Q1 2026 earnings report, filed April 29, 2026, argued otherwise. Revenue hit $1.10 billion, beating consensus by 4.9%, with EPS of $0.12 matching estimates for the fourth straight quarter. GAAP net income of $166.73 million rose 134.5% year over year, and loan originations set a record at $12.18 billion.
CEO Anthony Noto said, “We had an excellent Q1 delivering another quarter of durable growth and strong returns, fueled by our relentless focus on innovation and brand building.”
What Sparked the Bounce Recovery catalysts have stacked up quickly. On June 23, 2026, SoFi acquired Composer Securities and launched Composer by SoFi, an AI-powered investing platform. Noto argued, “As AI becomes a foundational part of investing, Composer by SoFi strengthens our ability to deliver powerful investing tools through an experience that is simple, intuitive, and accessible.” Days later, the company rolled out small business loans up to $250,000 with 24-hour funding.
Smart money has been leaning in. Cathie Wood’s ARK made four consecutive purchases, including over 200,000 shares (around $3.62 million) on June 30, 2026. Jim Cramer reiterated an “I Continue to Believe It’s Time to Buy” stance on June 23, 2026. For investors weighing how to play post-selloff setups, 24/7 Wall Street’s Breakout Buyers Rulebook covers the framework.
Read: Are you ahead, or behind on retirement? SmartAsset's free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don't waste another minute; learn more here.
The Bear Case Hasn’t Vanished The Muddy Waters overhang lingers. Signal Law Group followed up on June 27, 2026, with a Securities Disclosure Risk bulletin. Credit metrics are drifting: personal loan charge-offs rose to 3.0% from 2.8% sequentially, student loan charge-offs to 0.7% from 0.5%, and average asset yields fell 63 basis points. The Technology Platform segment shrank 27% after a large client departure.
Wall Street is unconvinced. The consensus rating is Hold, with an average target of $20.90. The forward P/E of 30x relative to 2026 guidance of approximately $0.60 in adjusted EPS leaves little room for error.
Verdict: Off the Lows, Not Yet Confirmed Shares have clearly recovered from the $16.03 low in early June, and the operational story continues to support the bulls. Whether $18 holds as a durable base depends on the July 29, 2026, Q2 earnings call, where analysts expect revenue of $1.1 billion and EPS of $0.11. Investors should monitor the stock and, more importantly, the charge-off trajectory.
If You’ve Been Thinking About Retirement, Pay Attention (sponsor) Retirement planning doesn’t have to feel overwhelming. The key is finding expert guidance, and SmartAsset’s simple quiz makes it easier than ever for you to connect with a vetted financial advisor. Here’s how:
Answer a Few Simple Questions.
Get Matched with Vetted Advisors
Choose Your Fit
Why wait? Start building the retirement you’ve always dreamed of. Get started today! (sponsor)
Omnicell za posledních 12 měsíců vzrostl o 52,6 % díky růstu SaaS a Expert Services, novým zakázkám u zdravotnických systémů a mezinárodní expanzi. Firma zároveň očekává v roce 2026 asi 12 milionů USD nákladů souvisejících s cly.
Key Takeaways Omnicell is expanding autonomous pharmacy solutions with SaaS, services and OmniSphere adoption.OMCL is benefiting from health system wins, international expansion and recurring subscription revenue.Omnicell expects tariff costs in 2026, while labor shortages and inflation remain operational challenges. Shares of Omnicell (OMCL - Free Report) have rallied 52.6% over the past year, significantly outperforming the industry’s 20.8% fall and the S&P 500 composite’s 23.9% gain.
Sporting a Zacks Rank #1 (Strong Buy) at present, the healthcare technology company continues to pursue the vision of the autonomous pharmacy, designed to improve medication management outcomes. Growth in SaaS and Expert Services, rising adoption among health systems and international expansion further strengthen its outlook.
Headquartered in Mountain View, CA, Omnicell develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs.
Factors Favoring OMCL’s GrowthOmnicell continues to advance toward its goal of achieving the industry-defined vision of autonomous medication management, which is a roadmap to improving operational efficiencies and ultimately targeting zero-error medication management. Over the past several years, Omnicell has evolved from offering a single-point solution to a platform of products and services and has also secured several wins with major health systems and government health care facilities. OMCL’s ongoing R&D investments across Points of Care, Central Pharmacy and IV Compounding, Specialty Pharmacy and 340B Program and Ambulatory Care market categories are expected to deliver solutions that drive positive medication management outcomes for customers.
Image Source: Zacks Investment Research
The company derives an increasing portion of revenues from its subscription-based SaaS and Expert Services offerings, which include a combination of robotics, smart devices and intelligent software, all optimized by expert services. In recent years, Omnicell has integrated three key acquisitions, such as Specialty Pharmacy Services (formerly ReCept), FDS Amplicare and MarkeTouch Media, LL (merged into EnlivenHealth, Inc), to broaden the offerings. In 2025, SaaS and Expert Services revenues were $259 million.
In the first quarter of 2026, several health systems committed to using Omnicell's inventory optimization service, alongside central pharmacy automation and point-of-care dispensing solutions. The company announced OmniSphere in late 2024, a cloud-native platform designed to unify all Omnicell products under a single, secure infrastructure to make it simpler, safer and more connected to manage medications within a growing health system. EnlivenHealth also continues to gain traction with cross-selling and upselling communication solutions to existing customers.
Healthcare providers outside the United States are becoming increasingly aware of the benefits of automation. There is a substantial demand for adherence packaging equipment outside the domestic market. Omnicell’s international operations include its sales efforts centered in Canada, Europe, the Middle East and the Asia-Pacific regions and supply-chain efforts in Asia. Given the fact that the international market is less than 1% penetrated, with very few hospitals adopting medication control systems, this creates a solid long-term growth opportunity.
Risks for OMCLSimilar to its health-care system partners, Omnicell’s operations continue to be affected by persisting labor shortages as well as increased inflationary costs related to components’ raw materials and freight. The company’s 2026 guidance incorporates an updated estimate of approximately $12 million in tariff-related costs impacting profitability.
A Glance at OMCL’s EstimatesThe Zacks Consensus Estimate for Omnicell's earnings per share (EPS) is pegged at $1.97 for 2026 and $2.23 for 2027, implying year-over-year growth of 21.6% and 13.2%, respectively. Over the past 60 days, the consensus estimate for 2026 EPS has moved up 5.3%, while the 2027 estimate has increased 2.3%.
Revenues for 2026 are projected to grow 4.9% to $1.24 billion, and another 4.2% to $1.30 billion in 2027.
Other Key StocksSome other top-ranked stocks in the broader medical space are Illumina (ILMN - Free Report) , Align Technology (ALGN - Free Report) and Integra LifeSciences (IART - Free Report) .
Illumina has an earnings yield of 2.8% compared to the industry’s negative 14.6% yield. Its earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 12.2%. ILMN shares have rallied 95.8% compared with the industry’s 25.6% growth over the past year.
ILMN carries a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Align Technology, carrying a Zacks Rank #2, has an estimated long-term earnings growth rate of 10.3% compared with the industry’s 5.5% growth. Shares of the company have dipped 6.3% against the industry’s 9.6% growth. ALGN’s earnings outpaced estimates in three of the trailing four quarters and missed on one occasion, the average surprise being 7.8%.
Integra LifeSciences, carrying a Zacks Rank #2, has an earnings yield of 13.7% against the industry’s negative 3% yield. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 16.7%. IART shares have rallied 33.8% against the industry’s 10.5% decline over the past year.
Key Takeaways NICE deepens AI leadership with Sopra Steria's CXone and Copilot deployment across three countries.Sopra Steria's CXone setup helps answer 90% of customer calls within 20 seconds. NICE's cloud revenues rose 14.6% in Q1 2026 and made up about 75% of the total revenues. NICE (NICE - Free Report) shares have declined 14% year to date, significantly underperforming the Zacks Computer & Technology sector’s return of 16.6%. The decline reflects investor concerns surrounding a slower enterprise spending environment, longer sales cycles and intensifying competition from Genesys, Five9, Salesforce (CRM - Free Report) and Microsoft (MSFT - Free Report) in the customer experience software market.
However, NICE remains focused on strengthening its enterprise (artificial intelligence) AI platform through continued cloud innovation and strategic customer wins. Sopra Steria, one of Europe’s leading technology consulting firms, has deployed NICE’s CXone and Copilot for Agents across its service centers in France, Poland and India. The deployment marks one of NICE’s first large-scale AI implementations in France and extends its presence across Europe’s growing enterprise AI market.
The cloud-based CXone platform is integrated with Sopra Steria’s IT service management tools, Active Directory and monitoring systems, providing intelligent routing, real-time reporting, interaction traceability and SLA management. The platform consolidates voice, email, chat and digital communications into a single agent interface, enabling Sopra Steria to answer 90% of customer calls within 20 seconds while improving customer experience and operational efficiency.
Sopra Steria's Digital Platform Services division, which manages more than 1.2 million inbound customer interactions annually, is using Copilot for Agents to provide real-time contextual guidance, recommended responses and automated interaction summaries. The deployment supports more than 2,000 employees, including nearly 800 AI-enabled agents and is expected to reduce agent workload, accelerate issue resolution and improve service quality. The deployment further expands NICE's international customer base and is expected to strengthen recurring cloud revenues over the long term.
AI Expansion Strengthens NICE’s ProspectsThe Sopra Steria deployment aligns with NICE’s broader strategy of expanding agentic AI across enterprise customer service operations. In the first quarter of 2026, the company launched CXone Mpower Orchestrator, an AI-powered platform that coordinates AI agents, human employees and business workflows across front, middle and back-office operations. NICE also introduced CXone Mpower Agents, autonomous AI agents that improve productivity by handling customer interactions with minimal human intervention.
NICE’s strong cloud execution and growing AI adoption reinforce its long-term growth prospects. Cloud revenues increased 14.6% year over year in the first quarter of 2026 and represented approximately 75% of the total revenues. Encouraged by this momentum, the company raised its 2026 revenue outlook to $2.92-$2.94 billion. The expanding AI portfolio is expected to strengthen NICE’s competitive position, drive higher cloud adoption and support sustainable recurring revenue growth over the long term.
NICE expects second-quarter 2026 revenues to be $761-$771 million. The Zacks Consensus Estimate for second-quarter 2026 revenues is pegged at $767.17 million, indicating 5.57% year-over-year growth.
The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $2.63 per share, which has been unchanged over the past 30 days. The figure implies a year-over-year decline of 12.62%.
NICE Faces Stiff CompetitionNICE faces increasing competition from Microsoft and Salesforce as both companies deepen their presence in AI-powered CX, contact center and enterprise automation markets.
Microsoft competes with NICE through its Dynamics 365 Contact Center, Microsoft Teams, Azure AI and Copilot ecosystem. The company is embedding generative AI, intelligent routing, real-time agent assistance and customer service automation into widely used enterprise productivity applications. Microsoft offers customers an integrated platform that reduces the need for standalone contact center solutions. Its vast enterprise customer base and Azure cloud infrastructure also strengthen its competitive position.
Meanwhile, Salesforce is intensifying competition through Service Cloud, Agentforce, Einstein AI and Data Cloud. The company enables enterprises to deploy autonomous AI agents, automate customer service workflows and unify customer data across sales, marketing and service functions. Salesforce’s broad CRM ecosystem, extensive partner network and deep enterprise relationships make it an attractive end-to-end customer engagement platform, challenging NICE in AI-driven customer experience management.
TTRF Capital v novém podání u SEC uvedl novou pozici v Nebius Group za odhadovaných 64,0 milionu USD, která na konci čtvrtletí vzrostla na 89,2 milionu USD.
A July 6, 2026 SEC filing shows TTRF Capital Ltd established a new Nebius Group N.V. (NBIS 4.13%) position estimated at $64.0 million using quarterly average pricing.
What happenedAccording to an SEC filing reported on July 6, 2026, the firm initiated its stake in the AI infrastructure provider. This entry into Nebius Group followed the company's rebranding from Yandex N.V. in August 2024. The stake's valuation reached $89.2 million by quarter-end. Separately, the firm reported 13 total equity positions in the quarter.
What else to knowThe July 6, 2026 filing confirms a new position for the firm, representing 58.8% of reported 13F assets.Top five holdings as of the filing date:Nebius Group (NBIS 4.13%): $89.2 million (58.8% of AUM)Palantir Technologies (PLTR +3.44%): $20.0 million (13.2% of AUM)AST SpaceMobile (ASTS 4.45%): $7.8 million (5.1% of AUM)SoFi Technologies (SOFI 2.15%): $7.7 million (5.1% of AUM)Meta Platforms (META +1.30%): $7.5 million (4.9% of AUM)Nebius Group has outperformed the S&P 500 index by about 300 percentage points over the past year.Company OverviewMetricValueShare Price (as of market close 2026-07-06)$215.08Market Capitalization$51.75 billionOne Year Total Return328.0%Employees1,371Company SnapshotNebius Group operates a comprehensive AI infrastructure platform that provides GPU computing clusters, cloud services, and developer tools to support demanding artificial intelligence workloads globally.The company generates revenue from its diversified portfolio, including Nebius (an AI cloud platform), Toloka AI (data solutions for generative AI development), TripleTen (technology education), and Avride (autonomous driving technologies).The company serves enterprise customers, AI developers, technology learners, and autonomous vehicle manufacturers seeking scalable infrastructure and specialized services within the artificial intelligence ecosystem.Nebius Group is a technology infrastructure company headquartered in Amsterdam with 1,371 employees and a market capitalization of $51.75 billion as of July 6, 2026. The company has established itself as a critical infrastructure provider for the global AI industry, leveraging its diversified business segments to address multiple facets of AI development and deployment. With operations spanning Europe, North America, and Israel, Nebius maintains a strategic focus on providing essential computational resources and specialized services that support the accelerating adoption of artificial intelligence technologies across enterprise and consumer applications.
What this transaction means for investorsTTRF Capital is a young firm running a concentrated portfolio heavy on technology-related names. Nebius appears to be the firm’s highest-conviction stock, with the only other pure-play AI cloud infrastructure supplier being Iren Ltd. (IREN 5.72%) Iren isn’t among its top five holdings, however.
Most investors should work to build a more diversified portfolio, including stocks beyond the technology sector. However, owning Nebius in the higher-risk, technology portion of any portfolio may make sense for those with the proper risk tolerance.
Nebius’ services are in high demand for their GPU capacity, and even AI-leader Nvidia (NVDA +0.90%) owned nearly 1.2 million Nebius shares as of March 31.
Investors should be aware that the market has already built significant potential business into Nebius’ valuation. Its $50 billion market cap is lofty even given the company’s projection of revenue at an annual run rate of $7 billion to $9 billion entering 2027. Positions should be allocated accordingly, and potential volatility should be considered as the company works to manage its fast-growing sales base.
Howard Smith has positions in Nvidia. The Motley Fool has positions in and recommends AST SpaceMobile, Meta Platforms, Nvidia, and Palantir Technologies. The Motley Fool has a disclosure policy.
CoreWeave za poslední rok spadla téměř o polovinu, protože Meta Platforms plánuje prodávat přebytečný výpočetní výkon. Firma navíc loni zvýšila tržby na 5,1 miliardy USD, ale čistá ztráta vzrostla z 937 milionů USD na 1,2 miliardy USD.
CoreWeave (CRWV 3.41%) has been struggling of late, and over the past year, its share price has been cut nearly in half. The company has experienced incredible growth due to artificial intelligence (AI) and businesses seeking out compute power, but it's been facing headwinds of late.
Recently, there's been some bad news for investors, with tech giant Meta Platforms announcing that it plans to create a business to sell excess compute power. Not only does that mean more competition for CoreWeave, but it also highlights a fairly big risk with the stock.
Image source: Getty Images.
CoreWeave's fundamental problem is a lack of moat While CoreWeave has benefited from surging AI-related demand for compute power, the big risk with its business is that there is no defendable competitive advantage, also known as a moat, to protect it from competition. That's why when big tech companies such as Meta offer up their excess compute power, it can have a devastating impact on CoreWeave's growth prospects. If the companies that once were in need of compute capacity recognize they don't need as much and begin selling it, that's bad news on multiple fronts for CoreWeave, as it signals an increase in competition and less demand.
At that stage, what CoreWeave may be left to do is to compete on price, which would make it more challenging for the company to get out of the red. Last year, while the company reported $5.1 billion in revenue, more than doubling the $1.9 billion it posted in the previous year, its net loss actually grew from $937 million to $1.2 billion.
Today's Change
(
-3.41
%) $
-2.95
Current Price
$
83.51
This is a highly risky and speculative stock to own As long as tech companies continue to invest heavily in AI, CoreWeave has the potential to grow significantly and see its share price rise. But as there are signs that isn't the case, such as companies signaling that they don't need as much compute power, then that can end up having the opposite effect, which is why CoreWeave's stock has been sinking of late.
CoreWeave is a speculative buy. For investors who believe there is still incredibly strong demand for all things AI-related, then CoreWeave may seem like a bargain. But for those who are a bit more skeptical, which is the group I'd fall into, it may not be as convincing that CoreWeave is a good buy right now, despite its reduced valuation. With significant losses, no significant competitive advantage, and an uncertain future, CoreWeave is an incredibly risky stock, and there's still plenty of room for it to fall further.
